University of New Mexico

UNM Digital Repository
Biomedical Sciences ETDs

Electronic Theses and Dissertations

5-1-2010

Perinatal arsenic exposure inhibits binding ability of
glucocorticoid receptors to nuclear response
elements altering gene expression and affecting
learning behavior
Ebany Martinez-Finley

Follow this and additional works at: https://digitalrepository.unm.edu/biom_etds
Recommended Citation
Martinez-Finley, Ebany. "Perinatal arsenic exposure inhibits binding ability of glucocorticoid receptors to nuclear response elements
altering gene expression and affecting learning behavior." (2010). https://digitalrepository.unm.edu/biom_etds/15

This Dissertation is brought to you for free and open access by the Electronic Theses and Dissertations at UNM Digital Repository. It has been
accepted for inclusion in Biomedical Sciences ETDs by an authorized administrator of UNM Digital Repository. For more information, please contact
disc@unm.edu.

PERINATAL ARSENIC EXPOSURE INHIBITS BINDING
ABILITY OF GLUCOCORTICOID RECEPTORS TO
NUCLEAR RESPONSE ELEMENTS ALTERING GENE
EXPRESSION AND AFFECTING LEARNING BEHAVIOR

BY

EBANY J. MARTINEZ-FINLEY
B.S., Biology, University of New Mexico, 2005
B.S., Spanish, University of New Mexico, 2005

DISSERTATION
Submitted in Partial Fulfillment of the
Requirements for the Degree of
Doctor of Philosophy
Biomedical Science
The University of New Mexico
Albuquerque, New Mexico

May, 2010

DEDICATION

To my parents, with love:

For my dad, Michael, who taught me to be self-reliant, showed me that hard work
and dedication pay off, and who took the word ‘can’t’ out of my vocabulary; you
are my favorite philosopher

and

For my mom, Annette, who taught me to read, encouraged my love of reading
and involved me in theater as a child; little did you know those would be great
tools for a scientist

iii

ACKNOWLEDGEMENTS

I acknowledge Dr. Andrea Allan, my advisor and dissertation chair, for the
freedom to explore my own ideas and for insight into the world of science.
I also thank my committee members, Dr. Kevin Caldwell, Dr. Laurie
Hudson, Dr. Jim Liu, and Dr. Daniel Savage, for their valuable recommendations
pertaining to this study and assistance in my professional development. To the
National Institute of Environmental Health, Pfizer Global Research and
Development, the Graduate and Professional Student Association at the
University of New Mexico, the College of Pharmacy and the legislature of the
state of New Mexico for the funding to pursue this line research.
To all of my family, thank you for your support and for dreaming with me.
To my father-in-law, Tom, whose babysitting made the writing of this
dissertation possible.
To my siblings, Justin, Audra and Dillon, you have been inspirations to me
all of my life. The bar is set, surpass it.
To my husband, Will, for your love, support and encouragement, thank
you for helping me pursue my dreams.
And finally, to my son, Maverik, you are my biggest accomplishment.

iv

PERINATAL ARSENIC EXPOSURE INHIBITS BINDING
ABILITY OF GLUCOCORTICOID RECEPTORS TO
NUCLEAR RESPONSE ELEMENTS ALTERING GENE
EXPRESSION AND AFFECTING LEARNING BEHAVIOR

BY

EBANY J. MARTINEZ-FINLEY

ABSTRACT OF DISSERTATION
Submitted in Partial Fulfillment of the
Requirements for the Degree of
Doctor of Philosophy
Biomedical Science
The University of New Mexico
Albuquerque, New Mexico

May, 2010

PERINATAL ARSENIC EXPOSURE INHIBITS BINDING ABILITY OF
GLUCOCORTICOID RECEPTORS TO NUCLEAR RESPONSE ELEMENTS
ALTERING GENE EXPRESSION AND AFFECTING LEARNING BEHAVIOR

By

Ebany J. Martinez-Finley

B.S. Biology

B.S. Spanish

PhD Biomedical Science

ABSTRACT
Learning deficits in children following arsenic (As) exposure via drinking
water have been epidemiologically described in the last decade. Arsenic is a
persistent environmental toxin and exposure has been shown to perturb the
hypothalamic-pituitary-adrenal (HPA) stress axis. The glucocorticoid receptors
(GR) are an integral part of the HPA axis and are found throughout the central
nervous system, particularly in the hippocampus, an area of the brain important
vi

in learning and memory. The mitogen-activated protein kinase (MAPK) pathway
is involved in learning and two kinases of the MAPK pathway, Ras and Raf are
transcriptionally regulated by GRs. In the studies detailed in this dissertation the
impact of perinatal exposure to 50 parts per billion (ppb) sodium arsenate on
learning behavior, GRs and MAPK pathway genes in the C57BL/6J adolescent
mouse were examined. Hippocampal-sensitive learning was assessed using a
novel object task and eight-way radial arm maze (RAM). Arsenic-exposed
offspring showed increased latency to the novel object and increased number of
entry errors in the RAM compared to controls. Immunoblotting revealed that
arsenic-exposed offspring had significantly lower levels of both GR and
mineralocorticoid receptors in the activated nuclear subcellular fraction than
controls. As-exposed mice also showed significantly lower Ras and Raf-1 mRNA
levels, assessed by real-time RT-PCR, compared to controls. Binding of the
glucocorticoid receptor (GR) to glucocorticoid response elements (GREs) in Ras
and Raf genes was measured by chromatin immunoprecipitation (ChIP). ChIP
revealed reduced binding of the GR to GREs in target genes in the As group.
Electrophoretic mobility shift assay (EMSA) revealed intact binding ability in both
control and arsenic-exposed offspring to a synthetic GRE. Results suggest that
moderate exposures to As can significantly reduce GR levels in the
hippocampus, affecting expression of genes that are under the control of the GR
and impacting learning behavior. Overall, these data suggest that moderate
levels of perinatal As can have a lasting impact on the brain and HPA axis of
offspring.
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Chapter 1. INTRODUCTION
1.1 Overview
Arsenic (As) is a naturally occurring metalloid and one of the most common
environmental contaminants. Arsenic is the 20th most abundant element in the
Earth’s crust and originates from volcanic tuff. It has several oxidation states but
those of greatest toxicologic importance are inorganic arsenite (AsIII) and
arsenate (AsV), the two forms that are also most commonly found in drinking
water. A common source of human exposure to inorganic arsenic is through
groundwater and drinking water contamination. In 1942, the EPA maximum
exposure limit of arsenic in drinking water was established at 50 parts per billion
(ppb). However, due to the extensive research on arsenic and carcinogenesis
the maximum contaminant level (MCL) was reduced to 10ppb (0.01mg/L) in
2006. Epidemiologic evidence links inorganic arsenic exposure to an increased
risk of a variety of cancers (i.e., lung, bladder, skin, kidney), type 2 diabetes,
vascular and cardiovascular disease, hypertension, genotoxicity and reproductive
and developmental anomalies (NRC, 2001). Many of these disease states can be
linked to problems with steroid or nuclear receptor-medicated gene regulation
(Barr et al., 2009). Arsenic is also a neurotoxin. While most studies on arsenic
have focused on its carcinogenic potential, a few studies suggest that arsenic
can adversely affect cognitive development in both rodents (Rodriguez et al.,
2001, 2002) and humans (Calderone et al., 2001). These studies and others
have prompted the National Research Council (NRC) to recommended additional
research in all areas of arsenic’s impact on human health. Specifically, the NRC
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stated, “A possible impact of arsenic exposure on neuro-cognitive development
in children requires further investigation” (National Research Council, 1999).
However, the effects of arsenic on nervous system function have received
considerably less attention than its association with cancer, genotoxicity, and
cellular disruption (Rodriguez et al., 2003). Literature describing the effects of
arsenic in drinking water on cognitive development is sparse. A PubMed search
for arsenic and any of the following key words cognitive development, cognition,
learning, memory, prenatal arsenic, perinatal arsenic, revealed less than 40
articles.

Arsenic

neurotoxicity

has

been

best

characterized

through

epidemiological studies, often based on research from countries (e.g., Mexico,
Taiwan, Bangladesh) with significantly higher arsenic concentrations than the
United States (Calderone et al., 2001; Wasserman et al., 2004; von Ehrenstein et
al., 2007). The majority of these studies have focused on adolescents; and
deficits in learning and memory, particularly in hippocampal-dependent tasks,
following acute and chronic arsenic exposure have been reported for both
rodents (Rodriguez, 2001, 2002) and humans (Calderone et al., 2001;
Wasserman et al., 2004; von Ehrenstein et al., 2007).
The mechanism through which it produces this damage is yet to be elucidated;
however, arsenic has been shown to perturb components of the hypothalamicpituitary-adrenal (HPA) stress axis, such as the glucocorticoid receptor (GR)
(Bodwell et al., 2004), by altering GR-mediated transcription. Perturbation of this
axis has been implicated in both cognitive damage and the promotion of
carcinogenesis. Persistent activation of the HPA axis in the chronic stress
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response probably impairs the immune response and contributes to the
development and progression of some types of cancer (reviewed in Reiche et al.,
2004). Studies on arsenic’s role in carcinogenesis have found that genes under
the control of the GR are sensitive to arsenic (Kaltreider et al., 2001) and they
may provide the link to arsenic-induced deficiencies in cognitive development. De
Kloet and colleagues showed that both the presence of glucocorticoids and a
functional GR are critical to normal hippocampal function (1998). Others have
also shown that, at intermediate levels, glucocorticoids enhance learning and
memory whereas low or high levels adversely affect cognition (Lupien and
McEwen, 1997). Glucocorticoid receptors are found throughout the central
nervous system (CNS) but are particularly concentrated in the hippocampus, an
area of the brain of central importance for learning and memory. A signaling
pathway that has been shown to be important in the processes of learning and
memory is the mitogen-activated protein kinase (MAPK) signaling pathway
(Atkins et al., 1998; Blum et al., 1999; Selcher et al., 1999; Shalin et al., 2004).
Two genes of the MAPK pathway, Ras and Raf, have promoters that contain
glucocorticoid response elements (GREs) which are activated upon binding of
GRs (Figure 1.1).
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Extracellular signal-regulated kinase 1/2 (ERK1/2) is the downstream target of
Ras and Raf activation; phosphorylation of ERK1/2 facilitates its entry into the
nucleus where its transcriptional targets play an important role in learning and
memory (Shalin et al., 2004). Several studies demonstrate a requirement for the
mitogen-activated protein kinase (MAPK)/extracellular signal regulated kinase
(ERK) cascade in hippocampal-dependent associative and spatial learning
(Sweatt, 2004). Glucocorticoid receptor activation is intimately coupled to ERK
phosphorylation. Thus, disruption of GR/GRE binding by arsenic could lead to
less Ras and Raf mRNA, ultimately leading to less phosphorylation of ERK1/2
(Figure 1.2).
The HPA axis and the MAPK signaling pathway may prove to be a common
pathway for the diverse effects of arsenic. The overarching hypothesis for these
studies was perinatal arsenic exposure alters HPA axis parameters and GR/GRE
interactions, leading to impairments in the MAPK signaling pathway which are
manifested as behavioral learning and memory deficits (Figures 1.1-1.2). The
goal of this research was to test this hypothesis by determining the effects of
moderate perinatal arsenic exposure on the HPA axis, the MAPK/ERK1/2
signaling pathway and cognition.

1.2 Introduction to Arsenic
The gamut of health effects after arsenic exposure can be attributed to whole
body organ distribution of arsenic after an oral exposure, such as via drinking
water. Inorganic arsenic is transformed in the body via one-carbon metabolism
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through a series of methylation and

reduction reactions, utilizing

S-

adenosylmethionine (SAM) as a donor of methyl groups. Methylarsonic acid
(MMA) and dimethylarsinic acid (DMA) are the main metabolites of this pathway
and are excreted in urine. Up until recently, this pathway was thought to be the
detoxification pathway but several studies have shown that the metabolites
themselves can also produce toxicity (Vahter, 2009). Both inorganic arsenic and
its metabolites easily pass the placental and blood-brain barriers (Lindgren et al.,
1984; Willhite and Ferm, 1984; Jin et al., 2006) Jin and colleagues showed that
DMA was the major metabolite found in the brains of offspring whose mothers
were exposed to 10 or 30ppm arsenate or arsenite in drinking water (2006).

Figure 1.3 Arsenic speciation in brain of prenatally arsenic exposed pups (Jin et al., 2006)

The high levels of DMA in brains of offspring may be due to the fact that
methylation of arsenic in women is increased during pregnancy (Concha et al.,
1998; Hopenhyan et al., 2003). The methylation of arsenic is influenced however,
by a number of factors including, but not limited to, genetic polymorphisms,
nutrition, exposure to other chemicals and level of arsenic exposure (ATSDR
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Arsenic, 2007). Although arsenic can readily cross the placental and blood-brain
barriers it is not excreted at high levels in breast milk. A study of Andean women
exposed to high concentrations (about 200ppb) of inorganic arsenic in drinking
water detected concentrations of arsenic in their breast milk from 0.0008 to 0.008
ppm (Concha et al., 1998). Although this study was not conducted in rodents, it is
generally accepted that the concentration of arsenic present in the breast milk is
negligible.

1.3 HPA axis, GRs and Effects of Arsenic
Arsenic has been shown to produce a number of effects on the hypothalamicpituitary-adrenal (HPA) stress axis (Baos et al., 2006), but there are no studies
assessing perinatal arsenic effects on the developing HPA axis using an in vivo
model. Research conducted in the last decade suggests that arsenic is a potent
endocrine disruptor (Bodwell et al., 2006, 2006; Kitchin and Wallace, 2005;
Kaltreider et al., 2001) and that moderate doses of arsenic can perturb
glucocorticoid receptors (GRs), which are an integral part of the HPA axis. These
receptors are not restricted to the brain but are distributed throughout the HPA
axis, and the body. The HPA axis is also critical to the development process and
anything that produces alterations in HPA axis during this time period is likely to
have significant ramifications for later function.
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Figure 1.4 HPA Axis Regulation (Erdmann et al., 2008)

The HPA axis functions through negative feedback regulation at the levels of the
hypothalamus, pituitary, and adrenals and additional regulation by the
hippocampus (Figure 1.4). HPA responses are initiated by secretion of
corticotrophin releasing factor (CRF) and arginine vasopressin (AVP) from
neurons of the medial parvocellular paraventricular nucleus (PVN) of the
hypothalamus through the portal blood system into the anterior lobe of the
pituitary. These hormones stimulate the release of adrenocorticotropic hormone
(ACTH) from the anterior pituitary into the systemic circulation. ACTH then
promotes the release of glucocorticoids from the adrenal cortex. Negative
feedback regulation exists to dampen the stress response, and glucocorticoids,
acting through GRs and MRs in the PVN and pituitary inhibit further
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glucocorticoid release via inhibition of CRF/AVP and ACTH release, respectively.
Glucocorticoids can also modulate HPA axis tone and activity by GR-mediated
inhibition in the hippocampus and medial prefrontal cortex via projections to the
PVN. Circulating glucocorticoids are required for proper control of gene
expression during development and homeostasis (Sun et al., 2008). There are
two types of receptors in the central nervous system that mediate the
glucocorticoid response. Mineralocorticoid receptors, also referred to as Type 1
receptors, have an affinity for glucocorticoids that is ten times higher than
glucocorticoid, or type 2 receptors. Therefore, in normal physiological states, MR
is activated at very low concentrations of glucocorticoids whereas GR remains in
the cytoplasm in its unactivated form until glucocorticoid concentrations reach
threshold levels. Because of its higher affinity for glucocorticoids, MR, under
normal physiological conditions, is thought to be fully occupied and thus, it is the
GR that mediates the actions of circulating high glucocorticoids activating stress
signaling. In the hippocampus there are abundant levels of glucocorticoids and
coexpression of both MR and GR (Nishi and Kawata, 2006) in both neurons and
glial cells. GRs can first be detected in rat brain on embryonic day (E17) (Kitraki
et al., 1984) and increase gradually to adult levels by postnatal day 15 (PND 15)
to PND30 (Olpe and McEwen, 1976; Clayton et al., 1977). Thus, the regulation of
HPA axis activity has been assumed to be established during the embryonic
development stage. MRs are located mainly in the hippocampus, whereas GRs
have a fairly wide distribution throughout the brain and central nervous system.
GRs and MRs regulate expression of genes involved in the maintenance of
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homeostasis (Bagchi et al., 1992) and because of their strong expression in the
limbic system of the brain they affect physiological processes such as
neurogenesis, synaptic plasticity and behavioral responses including learning,
memory, depression and anxiety (Erdmann et al., 2008).
At the cellular level, glucocorticoids cross the membrane by simple diffusion and
enter the cytosol of the cell, where they bind to the cytosolic GR. Once bound,
the hormone-receptor complex is translocated to the nucleus and regulates gene
transcription of a subset of genes. Distinct subsets of glucocorticoid target genes
are regulated differentially by MR or GR homodimers or MR/GR heterodimers
(Conway-Campbell et al., 2007). Transcriptional regulation is mediated through
binding to specific sequences of DNA named glucocorticoid response elements
(GREs). The outcome of transcription can either be enhancement or repression
of gene expression depending on whether GR binds to positive or negative
GREs (nGREs). It is not necessary to have direct interaction between GRs and
GREs in order to regulate gene transcription. Transcription can occur via direct
GR/GRE interaction or as GR tethered to other DNA-bound proteins (Webster
and Cidlowski, 1999). Other transcription factors known to be involved in the
regulation include NF-kB, AP-1 and CRE (Diamond et al., 1990). Gene activation
usually requires a 10-fold higher glucocorticoid concentration than gene
repression, even though the same GR-steroid complex is involved (Sun et al.,
2008). It has been estimated that approximately 1000-2000 genes in rat cortical
neuronal cells are under the control of glucocorticoids, with an equal number
being repressed and induced (Kino et al., 2007). Kaltreider and colleagues have
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shown that nontoxic doses of arsenite can interact directly with GR complexes
and selectively inhibit GR-mediated transcription (Kaltreider et al., 2001).
Concentrations of arsenic in the 0.1-0.7uM range were shown to stimulate
transcription of the tyrosine aminotransferase gene and the reporter genes
containing tyrosine aminotransferase glucocorticoid response elements in rat
hepatoma cells. At higher concentrations (1-3uM), the effects of arsenic on GRmediated gene activation are inhibitory (Bodwell et al., 2006). Hamilton and
colleagues showed that a single, low dose of arsenite (100µmol/kg sodium
arsenite in 100uL H2O) significantly altered basal and inducible mRNA
expression of the GRE-controlled phosphoenolpyruvate carboxykinase gene in
cell culture and in a whole-animal model (1998). They also showed that arsenite
had no effect on expression of GRE-non-inducible or constitutively expressed
genes (Hamilton et al., 1998). Micromolar amounts of inorganic arsenic can
inhibit transcription mediated by other members of the superfamily of nuclear
receptors including the mineralocorticoid receptor, the progesterone receptor, the
androgen receptor, the estrogen receptor, the thyroid hormone receptor and the
retinoic acid receptor (Kaltreider et al., 2001; Davey et al., 2007; Bodwell et al.,
2004; Davey et al., 2008). Based on these studies and the lack of receptor
specificity, it is possible that there is a common target for arsenic, but this
mechanism is yet to be elucidated. All of these receptors use a common
mechanism of activation of gene transcription following ligand binding, allowing
them to respond to a broad range of stimuli.
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These studies have yet to characterize the effects of arsenic in an in vivo rodent
model. Although there is information about arsenic in these various cell culture
and chick embryo models there is no information about perinatal exposure to
arsenic and its effects on GR-mediating gene transcription. Thus we are aware of
potential damage produced by arsenic but these models don’t account for what is
happening when the whole system is intact and allowed to compensate for the
damage.

1.4 Role of GR in Hippocampal-dependent Learning and Memory
and Deficits in Arsenic-exposed populations
The connection between the hippocampus and learning and memory has been
well established for decades (O’Keefe and Nadel, 1978). De Kloet and
colleagues showed that both the presence of corticosteroids and a functional GR
are critical to normal hippocampal function (De Kloet et al., 1998). Deficits on
plasticity or memory in rats and humans are correlated with a high increases in
plasma glucocorticoid (i.e. cortiocosterone and cortisol, respectively) that activate
GRs (Lupien and McEwen, 1997; Belanoff et al., 2001, Diamond et al., 1992).
Others have also shown that, at intermediate levels, corticosteroids enhance
learning and memory but low or high levels adversely affect cognition (Lupien
and McEwen, 1997). GRs have been shown to be involved in consolidation of
learned information (De Kloet et al., 1999) and MRs involved in interpretation of
novel information (Berger et al., 2006), memory retrieval (Conrad et al., 1997),
and visuospatial learning (Yau et al., 1999). Animal studies have shown that
intracerebroventricular injection of a rather selective MR antagonist in rats
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influenced corticosterone-induced behavioral reactivity to spatial novelty (Oitzl et
al., 1994). Mice with loss of limbic MR, via Cre-loxP inactivation, showed normal
open field behavior and normal radial arm maze performance but impairments in
behavioral reactivity to novelty (Berger et al., 2006), suggesting the MRs control
behavioral response to novelty. GR is implicated in memory consolidation
processes, demonstrated by using GR-agonists and GR-antagonists (Oitzl et al.,
2001; Donley et al., 2005; Oitzl and deKloet, 1992; Roozendaal., 2003; Sandi
and Rose, 1994). Intracerebral ventricular injection of a GR antagonist after
training in the water maze task resulted in increases in latencies to find the
platform (Oitzl and deKloet, 1992). Oitzl and colleagues showed that mice
deficient in GR DNA-binding showed selective impairment of spatial memory in
the water maze (Oitzl et al., 2001). Donley and colleagues showed hippocampal
administration of GR antagonist RU 38486 decreased freezing in a 24 hour
contextual fear conditioning retention test while post-shock levels of freezing
were intact (Donley et al., 2005). We assessed MR and GR levels in our perinatal
model due to their involvement in learning and memory and the fact that arsenic
neurotoxicity has been best characterized through epidemiological studies of
learning and memory deficits (Calderone et al., 2001; Wasserman et al., 2004;
von Ehrenstein et al., 2007). One potential setback with these studies is that they
are all retrospective and there may be a time interval between the exposure and
the production of learning and memory deficits. In addition there may be
covariants that are not reported such as other chemical exposures or nutrition
which can not be controlled. One cross-sectional study conducted in Mexico
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examined the effect of chronic arsenic and lead exposure on learning and
memory. This study examined two populations with a total of 80 children, ages 69, one living close to a smelter and the other living in a lower arsenic
concentration area. They compared test scores of both groups using the
Wechsler Intelligence Scale for Children revised for Mexico (WISC-RM) and
reported that higher levels of urinary arsenic were correlated with poorer
performance on tests examining long-term memory after correcting for lead
exposure levels (Calderone et al., 2001). Another cross-sectional study
conducted in Taiwan, with 109 adolescents, reported significant effects of longterm cumulative exposure to arsenic on memory and switching attention after
adjusting for education and sex (Tsai et al., 2003). A study conducted in
Bangladesh, with 201 children, age 10, using the WISC, reported that the
children’s intellectual function was reduced in relation to exposure to arsenic in
drinking water. This study corrected for manganese, which was also present in
high amounts in their water source and socioeconomic factors. With covariate
adjustment they found that children with arsenic levels above 50ppb achieved
significantly lower performance and full-scale test scores than children with
arsenic levels below 5ppb (Wasserman et al., 2004). Another study conducted in
India with 351 children, ages 5 to 15 years, using the WISC, in conjunction with
the Colored Progressive Matrices test, and the Total Sentence Recall test
reported significant associations between urinary arsenic levels and performance
in the vocabulary test, the object assembly test and the picture completion test.
These studies provide a basis for arsenic toxicity and neurobehavioral effects.
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Cross-sectional studies analyze the relationship between different variables at a
point in time and since exposure and disease status are measured at the same
point, it may not always be possible to distinguish whether the exposure
preceded or followed the disease. Thus, we have limited information on sensitive
time periods of exposure and the mechanisms involved in the deficits. Our
perinatal arsenic mouse model is useful for determining if the neurobehavioral
outcomes could be the result of exposure to arsenic during the sensitive perinatal
time period. Our rodent model also provides a way to measure outcomes without
confounds such as socioeconomic status, nutrition, intelligence and other
chemical exposures. In addition, it is possible to look at the brain molecularly and
biochemically to help establish a mechanism for the behavioral learning and
memory deficits.

1.5 GRs as Transcriptional Regulators of Genes in the MAPK/ERK
Signaling Pathway
While there are several neurochemical pathways involved in learning and
memory processes, the mitogen-activated protein kinase (MAPK) pathway
appears to provide a final common pathway for the many neurotransmitter
systems involved in memory. Several studies support a requirement for the
MAPK/extracellular signal regulated kinase (ERK) cascade in hippocampaldependent associative and spatial learning (Sweatt, 2004). MAPKs are prolinedirected, serine/threonine kinases that regulate a variety of cellular functions.
MAPKs are converted to the active, phosphorylated form by dual-specificity
kinases,

MAP

kinase

kinases

or

MAPK/ERK
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kinases

(MEKs),

which

phosphorylate threonine and tryrosine residues in the enzymes. Two of the
genes of importance in regulating MAPK phosphorylation, Ras and Raf, have
been shown to be activated by GR binding to GREs (Revest et al., 2005). Ras
and Raf expression activates the MAPK signaling pathway ultimately leading to
phosphorylation and activation of ERK1/2. Phosphorylated ERK (p-ERK) is
translocated to the nucleus where it activates a number of genes. There is
evidence that ERK1/2 activation occurs in rodents after training in a spatial
learning task, such as the hidden platform version of the Morris Water Maze
(Blum et al., 1999), as well as after fear conditioning (Atkins et al., 1998).
Intrahippocampal infusions of MAPK pathway inhibitors, prior to training, impair
memory retention after training in the Morris Water Maze (Blum et al., 1999;
Selcher et al., 1999). Shalin and colleagues used transgenic mice to show that
neuronal MEK and subsequent ERK1/2 activation has an important role in
hippocampal-dependent learning (Shalin et al., 2004). These transgenic mice
were constructed to express a dominant-negative form of MEK, specifically in the
hippocampus and thus they also had decreased levels of ERK1/2 activity in the
hippocampus (Shalin et al., 2004). The transgenic mice showed normal
performance in a battery of control tasks, such as open field, rotarod and shock
threshold, but displayed significant impairments in contextual fear conditioning
compared to their wild type littermates (Shalin et al., 2004) indicating an
impairment in higher order functions. MEK activation and rapid ERK activation is
critical for induction of long-term potentiation (LTP), the basis for learning at the
synaptic level. ERK activation is also important in delayed gene expression
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responses that come into play at a later stage of LTP in the hippocampus
(Mailliet et al., 2008). To our knowledge no one has characterized the effect of
perinatal arsenic exposure on the MAPK signaling pathway in the brain and its
association with learning and memory deficits.

1.6 Summary
Based on the epidemiological studies that reported decrements in learning and
memory in children exposed to arsenic via their drinking water (Calderone et al.,
2001; Tsai et al., 2003; Wasserman et al., 2004; von Ehrenstein et al., 2007) we
postulated that learning and memory would be impaired in mouse offspring born
to arsenic-exposed mothers. In chapter three, we report nonspatial learning and
memory using the novel object task and spatial learning and memory using the 8way radial arm maze in 35 day old male mice exposed perinatally to 50 ppb
arsenic in drinking water (Martinez-Finley et al., 2009). The 35 day time period
was chosen because at this time point mice are equivalent in age to
children/adolescents which were reported in the epidemiology studies. Figure 1.5
shows an age equivalency in mice and humans.
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Figure 1.5 Human and Mouse Age Equivalencies
(http://research.jax.org/faculty/harrison/ger1vLifespan1.html)

Chapter three shows the level of arsenic found in the whole brains of our mice
after perinatal exposure (Martinez-Finley et al., 2009). Arsenic levels in the
hippocampal region were below the limit of detection in both control and perinatal
arsenic-exposed offspring (unpublished observation). Chapter two reports the
results of measurements of basal levels of corticosterone (CORT) using
radioimmunoassay techniques from perinatally arsenic exposed mice along with
their respective controls (Martinez et al., 2008). To address the status of the
receptors mediating the CORT response and the learning and memory we report
MR and GR protein levels within hippocampal tissue from 35 day old mice
perinatally exposed to 50 ppb arsenic or control tap water (Martinez-Finley et al.,

18

2009)

in

chapter

three.

The

appendicies

contain

information

on

the

developmental vs. acute postweaning time periods. Chapter four is the
assessment of the functional status of the GR-associated MAPK signaling
pathway determined by measuring Ras and Raf mRNA levels using Real-Time
PCR. We also measured the impact of reduced levels of upstream kinases, Ras
and Raf, by assessing the ratio of phosphorylated ERK (p-ERK) to total ERK
using western blot. We hypothesized that arsenic inhibits GR binding to the
GREs in the promoter regions of Ras and Raf, thereby inhibiting transcription of
these genes. To evaluate the level of GR binding to the GRE site on the Ras and
Raf promoters we utilized Chromatin Immunoprecipitation of GR in arsenictreated and control animals. Co-immunoprecipitated genomic DNA sequences
were subjected to real-time PCR with primers for the promoter sequence of Ras
and Raf.
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Chapter 2. MODERATE PERINATAL ARSENIC EXPOSURE ALTERS
NEUROENDOCRINE MARKERS ASSOCIATED WITH DEPRESSION AND
INCREASES DEPRESSIVE-LIKE BEHAVIORS IN ADULT MOUSE
OFFSPRING

Ebany J. Martinez, Bethany L. Kolb, Angela Bell, Daniel D. Savage,
and Andrea M. Allan
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2.1 ABSTRACT
Arsenic is one of the most common heavy metal contaminants found in the
environment, particularly in water.

We examined the impact of perinatal

exposure to relatively low levels of arsenic (50 parts per billion) on
neuroendocrine markers associated with depression and depressive-like
behaviors in affected adult C57BL/6J mouse offspring.

Whereas most

biomedical research on arsenic has focused on its carcinogenic potential, a few
studies suggest that arsenic can adversely affect brain development and neural
function.
Compared to controls, offspring exposed to 50 parts per billion arsenic during the
perinatal period had significantly elevated serum corticosterone levels, reduced
whole hippocampal CRFR1 protein level and elevated dorsal hippocampal
serotonin 5HT1A receptor binding and receptor-effector coupling. 5HT1A receptor
binding and receptor-effector coupling were not different in the ventral
hippocampal formation, entorhinal or parietal cortices, or inferior colliculus.
Perinatal arsenic exposure also significantly increased learned helplessness and
measures of immobility in a forced swim task.
Taken together, these results suggest that perinatal arsenic exposure may
disrupt the regulatory interactions between the hypothalamic-pituitary-adrenal
axis and the serotonergic system in the dorsal hippocampal formation in a
manner that predisposes affected offspring to depressive-like behavior. These
results are the first to demonstrate that relatively low levels of arsenic exposure
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during development can have long-lasting adverse effects on behavior and
neurobiological markers associated with these behavioral changes.
Key Words: Arsenic, Corticosterone, Hippocampal Formation, CRF Receptor,
Serotonin Receptor, Learned Helplessness

2.2 INTRODUCTION
Failure to appropriately respond to external stressors has been implicated in a
number of mental health disorders, particularly Major Depressive Disorder
(Herman et al., 2003; Barden, 2004). Several lines of evidence suggest that
HPA axis hyperactivity, due to excessive corticotrophin-releasing factor (CRF)
release, combined with deficits in the negative feedback regulation of CRF
release (Barden, 2004), may be a causative factor in the pathogenesis of
depression (Pariente, 2004).

In addition, elevated corticosterone levels have

been associated with depression in a rodent model (Zhao et al, 2008). Elevated
CRF release in response to stress is associated with onset of depression
(Nemeroff 1992; Reul and Holsboer, 2002) and elevated cerebral spinal fluid
levels of CRF have been reported in depressed patient populations (Nemeroff,
1988).
Several studies indicate functional interactions between CRF and the
serotonergic system and have linked these interactions to depression (Leonard,
2005; Waselus and Van Bockstaele, 2007). In addition to CRF receptors present
in the raphe nucleus (Sakanaka et al, 1987; Swanson et al, 1983; Ruggiero et al,
1999; Kirby et al, 2000; Lowry et al, 2000; Valentino et al, 2001), CRF exerts a
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stimulatory effect on hippocampal serotonin (5HT) levels (Linthorst et al., 2002;
Peñalva et al., 2002; Oshima et al., 2003). CRF receptor antagonists reduce
5HT levels in rat hippocampal formation (Isogawa et al, 2000; Linthorst et al,
2002). Homozygous CRFR1 knockout mice showed enhanced hippocampal 5hydroxyindoleacetic acid (5-HIAAA) under basal conditions and a greater rise in
hippocampal 5HT during a forced swim task compared to wild type mice
(Peñalva et al., 2002). The most abundant 5HT receptor in the hippocampus is
the 5HT1A receptor and its expression is regulated by HPA axis activity (Lopez et
al., 1998); with expression being elevated during low corticosteroid conditions
and decreased with high corticosteroid levels.

Similarly, rats bred for high

anxiety-related behavior (HAB) have lower 5HT1A expression compared to the
low anxiety-related behavior rats (Keck et al., 2004).
Arsenic is one of the most common environmental contaminants found in water,
food and air (DeSesso et al., 1998). Human exposure has been associated with
skin, lung, and bladder cancers, vascular diseases, hypertension, and diabetes
(National Research Council, 2001; Kitchin, 2001). In addition, arsenic crosses
the placental barrier (Jin et al, 2006) and can affect offspring during critical
periods of brain development. Exposure has also been implicated in damaging
the hypothalamic-pituitary-adrenal (HPA) axis (Delgado et al., 2000) leading to
deficits in stress responding.
Given the reported effects of arsenic exposure on HPA axis responsiveness and
the putative interactions between the HPA axis and the serotonergic system in
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depression, we examined the impact of moderate perinatal arsenic exposure on
neuroendocrine markers associated with depression and depressive-like
behaviors in mice. Because the perinatal exposure period encompasses the
developmental period of the offspring from conception through embryonic stages,
gestational stages, and postnatal stages until weaning, it is likely that a number
of systems in the brain that are developing during these critical periods are
affected. For example, 5HT1A immunoreactivity has been shown as early as
embryonic day 16 (Patel and Zhou, 2005) suggesting that this system is
organized early on and could be affected in our model. We hypothesized that
moderate arsenic exposure during the perinatal period would alter markers of the
HPA axis and serotonergic neurotransmission and that these changes would be
consistent with the appearance of depressive-like behavioral responses in
affected offspring.

2.3 MATERIALS and METHODS
2.3.1 Perinatal Arsenic Exposure Paradigm
The arsenic exposure paradigm and behavioral tasks employed in these studies
were approved by the UNM Health Sciences Center Institutional Animal Care
and Use Committee. All mice were bred and maintained on a 12-hour light/dark
cycle (lights on from 0700 to 1900) with food and water ad libitum in a
temperature controlled (22 ºC) room in the Animal Resource Facility. Female
C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME) were assigned to either
a control arsenic-free water or 50 parts per billion (ppb) arsenic (sodium
arsenate, Sigma) water treatment group. Arsenic-free water was prepared by
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reverse osmosis followed by a MilliQ water purification step. After a two-week
acclimation period on the treated waters, male breeder mice were introduced into
each female’s cage. Three days later, the males were removed from the cages
and nesting material was placed in the female’s cage.

Mouse dam water

consumption was monitored throughout pregnancy and the dams continued to
drink the treated waters until their offspring were weaned.

Litter sizes and

neonatal body weights were measured on postnatal day 7.

Offspring were

weaned at 23 days of age and maintained in same-sex, litter-mate housed cages
with ad libitum access to untreated tap water and standard mouse chow until
they were used in experimental procedures at 75 to 90 days of age. Tap water at
UNM contains approximately 2 to 5 parts per billion arsenic. Mice (one per litter;
5-10 litters total per treatment group) were assigned to either one of the
biochemical assay procedures or one of the two behavioral testing paradigms.
Offspring used in behavioral studies were not used in biochemical studies.

2.3.2 Plasma Corticosterone
Blood samples were collected between 0800 and 1000 hours.

Mice were

decapitated and trunk blood collected into plastic SAFE-T-FILL capillary tubes
prepared with liquid EDTA Di Potassium Salt (Ram Scientific Inc, Yonkers, NY).
Tubes were immediately placed on ice and the plasma obtained by centrifugation
(4000 rpm x 15 minutes) at 4oC. Supernatents were decanted into storage tubes
and the samples frozen at -20 oC until assay. Plasma samples were then thawed
and assayed for corticosterone using a rodent double antibody 125I-corticosterone
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radioimmunoassay kit (MP Biomedicals, Orangeburg, NY), according to the
manufacturer’s instructions. Samples were assayed in duplicate.

2.3.3 CRFR1 Receptors
Tissue preparation. Adult offspring, 75 to 90 days of age, were sacrificed by
decapitation and whole hippocampal formation rapidly dissected, rinsed,
transferred to Dounce homogenizing tubes containing 0.5 mL homogenizing
buffer (0.32 M sucrose, 1 mM EDTA, 20 mM Tris-HCL and 0.1 mM AEBSP; HB
buffer) and homogenized by five loose and five tight up and down strokes.
Homogenates were centrifuged at 1,000xg for 6 minutes, the supernatant fraction
(S1) collected and centrifuged at 200,000xg for 30 min. The resulting pellet (P2)
was resuspended with 0.5 mL HB buffer with 75 mM NaCl, 75 mM KCl and 1%
Triton X-100 added, re-homogenized and centrifuged at 200,000xg for 30 min. to
produce detergent-soluble proteins (S3).

Aliquots of S3 were snap-frozen in

liquid nitrogen and stored at -80 ºC until assay.
Western blotting for CRFR1 receptor levels. The S3 membrane extracts were
thawed on ice, diluted in 4X SDS-PAGE sample buffer and heated at 70 ºC for 10
minutes.

Samples (1ug protein per well) were then separated using 7%

NuPAGE Tris-acetate gels (Invitrogen, Carlsbad, CA) and transferred to 0.45μm-think nitrocellulose membranes.

The membranes were blocked with 5%

nonfat dry milk in TBS-T (25 mM Tris-HCL pH 7.2, 150 mM NaCl and 0.05%
Tween-20) overnight at 4 ºC.

Blots were then incubated with a polyclonal

primary antibody to CRFR1 (1:200; Santa Cruz H-215) in 5% nonfat dry milk and
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TBS-T for 2 hours at room temperature.

The reaction was stopped with six

consecutive 10-minute washes in TBS-T. A goat anti-rabbit IgG (H+L):HRP
(1:5000; Pierce) was used for the secondary antibody incubation in 5% nonfat
dry milk and TBS-T for one hour at room temperature. The reaction was stopped
with six consecutive ten-minute washes in TBS-T.

Membranes were then

incubated in Supersignal West Pico Working Solution (Pierce) for five minutes
and exposed to CL-Exposure film (Pierce). Film was developed in Kodak D-19
developer then washed and fixed in Kodak fixer.

The developed film was

scanned (Hewlett Packard Scan Jet 5P) and immunoreactivities quantified by
measurements of optical densities using BioRad Quantity-One analysis software.
Each protein sample was run in duplicate and the average optical density
determined. B-actin was used as a loading control. The optical density
measurements, obtained from internal standards, were linear over the range of
10 to 50 µg of whole brain homogenate. For experimental samples with optical
densities in the linear range of the standard curve, the amount of
immunoreactivity was defined by dividing the optical density of the sample by the
optical density of one unit of immunoreactivity as determined by the standard
curve. The antigen protein level in the sample was then determined by dividing
the units of antigen present by the total μg of protein loaded on the SDS-PAGE
gel.

2.3.4 Serotonin 5HT1A Receptor Number and Receptor-Effector Coupling
Histological Sectioning. Adult offspring, 75 to 90 days of age, were sacrificed by
decapitation. Whole brains were rapidly dissected, frozen in isopentane, chilled
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in a dry ice/methanol bath and then stored in airtight containers at -80 oC until
sectioning. Ten-μm-thick coronal sections were collected at atlas coordinates,
interaural 2.10 mm, bregma -1.70 mm, according to mouse stereotaxic atlas of
Franklin and Paxinos (1997; atlas Figure 45). The brain was then rotated ninety
degrees to collect horizontal sections containing the ventral hippocampal
formation, entorhinal cortex and inferior colliculus. The level of sectioning in
each plane was verified by examination of Nissl-stained sections prior to the
collection of sections for the binding assays. The sections were thaw-mounted
onto precleaned Superfrost-Plus® microscope slides (VWR Scientific, West
Chester, PA) and stored at -80 oC in airtight containers until assay.
[3H]-DPAT

Binding

Assay.

The

binding

of

[3H]-(+)-8-Hydroxy-2-

dipropylaminotetralin hydrobromide ([3H]-DPAT) to 5HT1A receptors was
conducted according the methods reported by Hensler et al., (1991). Sections
were preincubated for 30 minutes in incubation buffer (150 mM Tris-HCl, pH 7.6
at 25 oC). Sections were then incubated with 2 nM [3H]-DPAT (200 Ci/mmole,
Amersham, Piscataway, NJ) for 60 minutes at 25 oC in the absence or presence
of 20 μM unlabelled DPAT. After incubation, sections were rinsed twice for five
minutes each in ice-cold incubation buffer, quickly dipped in ice-cold distilled
water, dried under a stream of cool air, vacuum desiccated overnight and then
loaded into x-ray cassettes along with tritium standards. A 20.3 x 25.4 cm sheet
of Biomax MR Film (Kodak, Rochester, NY) was apposed to the standards and
sections and exposed for eight weeks. After exposure, the film was developed in
Kodak D-19 developer (1:1) at 18 oC for 5 minutes, fixed for 5 minutes in Kodak
28

Fixer, rinsed and dried. For ease of handling and protection of the emulsion, the
film was cut into 2 x 5 cm strips and mounted onto clean microscope slides with
Permount.
DPAT-Stimulated [35S]-GTPγS Binding Assay.

Agonist-stimulated [35S]-

guanosine 5’-(γ-thio) triphosphate ([35S]-GTPγS) binding was conducted using the
methods originally reported by Sim et al. (1995).

Tissue sections were

preincubated for 10 minutes in incubation buffer (50 mM Tris-HCl, 100 mM NaCl,
5 mM MgCl2, pH 7.4 at 25 oC) containing 1 mM DL-dithiothreitol, 0.2 mM EGTA
and 2 mM guanosine 5'-diphosphate. Sections were then incubated with 100 pM
[35S]-GTPγS (specific activity = 1250 Ci/mmole; Perkin Elmer Life Sciences,
Boston, MA) for 90 minutes in the absence or presence of 10 μM unlabeled
GTPγS).

DPAT-stimulated [35S]-GTPγS binding was assessed by incubating

sections in the presence of 2 μM or 20 μM unlabelled DPAT. After incubation,
sections were rinsed twice for 15 seconds each in fresh incubation buffer at 4 ºC,
dipped for one second in 4 ºC distilled water, dried under a stream of cool air and
then vacuum desiccated overnight.
cassettes along with
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Sections were then loaded into x-ray

carbon standards and a sheet of Biomax MR Film was

apposed to the standards and sections and exposed for four days.

Film

development, fixation and subsequent handling were the same as described for
the [3H]-DPAT assay above.
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2.3.5 Quantitative microdensitometry
Microdensitometry was performed using Media Cybernetics Image Pro Plus®
(Silver Spring, MD) on an Olympus BH-2 microscope at a total image
magnification of 3.125X.

In each assay, an optical density standard curve,

expressed in picoCuries/105 μm2, was established based on the autoradiograms
of the standards. In the coronal sections, optical density measurements of ligand
binding were made in two brain regions, the dorsal hippocampal CA1 and in the
parietal cortex (Layers I-III) immediately above the dorsal hippocampal region. In
horizontal

sections,

binding

measurements

were

made

in

the

ventral

hippocampal CA1, the medial entorhinal cortex (Layers I-III) and in the inferior
colliculus.
In the [3H]-DPAT binding assay, total [3H]-DPAT binding in each brain region of
interest was measured in quadruplicate sections incubated in the absence of
excess unlabelled DPAT.

Non-specific [3H]-DPAT binding was measured in

duplicate sections incubated in the presence of 20 µM unlabelled DPAT. Specific
[3H]-DPAT binding in each brain region of interest was defined as the difference
between total and non-specific [3H]-DPAT binding.
In the [35S]-GTPγS binding assay, total [35S]-GTPγS binding in each brain region
of interest was measured in quadruplicate sections incubated in the absence of
excess unlabelled GTPγS. Non-specific [35S]-GTPγS binding was measured in
duplicate sections incubated in the presence of 10 µM unlabelled GTPγS. Basal
[35S]-GTPγS binding in each brain region of interest was defined as the difference
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between total and non-specific [35S]-GTPγS binding.

DPAT-stimulated [35S]-

GTPγS binding was measured in triplicate sections incubated in the presence of
one of two concentrations of unlabelled DPAT. DPAT-stimulated [35S]-GTPγS
binding was defined as the difference between [35S]-GTPγS binding in the
presence of DPAT and basal [35S]-GTPγS binding.
In a preliminary [35S]-GTPγS binding study, brain sections were incubated with
twelve different concentrations of DPAT ranging from 50 nM to 30 µM. DPAT
increased [35S]-GTPγS binding in a concentration-dependent manner between
200 nM and 20 µM DPAT (data not shown).

At 20 µM DPAT, [35S]-GTPγS

binding in the dorsal hippocampal formation was seven-fold higher than basal
[35S]-GTPγS binding.

The apparent EC50 for DPAT-stimulated [35S]-GTPγS

binding was 2 µM. Based on this study, 2 µM and 20 µM DPAT were selected as
EC50 and EC100 concentrations for the study of 5HT1A agonist-stimulated [35S]GTPγS binding in perinatal arsenic-exposed offspring.

2.3.6 Learned Helplessness Task
The learned helplessness task was performed in a Coulbourn™ Habitest© shuttle
box apparatus using training and testing procedures modified from a method
described by Caldarone et al. (2000). Each experimental group consisted of five
animals (one mouse per litter per group) in each of eight experimental groups:
Two perinatal treatments (control or arsenic) X two genders (male or female) X
two training groups (shock or no shock). Mice in the learned helplessness (LHtrained) groups received 120 uncontrollable and unpredictable foot shocks (0.5
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mA, 5 second duration) over the course of one hour. The probability for delivery
of a foot shock was 50% for every 15 second interval. The mouse was removed
from the shuttle box 30 seconds after the delivery of the 120th footshock. The
non-shocked (NS-trained) groups were placed into the shuttle box apparatus for
one hour during which no foot shocks were delivered. Two mice were trained at
a time, one LH-trained and one NS-trained. Mice were returned to their home
cages after the one-hour training session.

Twenty-four hours later, escape

latencies were measured using an active avoidance procedure. Animals were
placed into the shuttle box and given 30 trials with an inter-trial interval of 30
seconds. Latency for the mouse to escape through the door was measured as
the time from the door rising to the time it closed. If no escape was made 24
seconds after the start of the trial, the shock terminated and the door closed.

2.3.7 Forced Swim Task
Eight animals from each group (arsenic-exposed and control) were tested. Mice
were placed in a 30 cm diameter, 46 cm tall cylinder of water (22-25°C, depth 26
cm) and forced to swim for 3 minutes as described previously (Sunal et al., 1994;
Porsolt et al, 1977).

The combination of floating, twitching and paddling

behaviors represented immobility indicative of depressive-like behavior. Time
spent in immobile behaviors was scored during the three minute period. The sum
of thrashing, climbing and swimming behaviors were defined as escape-directed
behaviors and were not actively scored.
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2.3.8 Statistical Analysis
All data were analyzed either by t-test (Table 1 and Figures 2.1, 2.2, and 2.7) or
one or two-way ANOVA (Figures 2.5 and 2.6) using SPSS Version 14 (Chicago,
IL). When an ANOVA was performed, a t-test was performed as the post-hoc
test.

2.4 RESULTS
2.4.1 Perinatal Arsenic Exposure Paradigm
The perinatal arsenic exposure paradigm produced no significant differences in
litter size or offspring body weight at seven days of age (Table 1). Furthermore
offspring body weight, within the same gender, were not different between the
treatment groups (t(15) = 1.92; ns).

2.4.2 Plasma Corticosterone Levels
Plasma corticosterone levels were significantly elevated compared to control
offspring. Figure 2.1 represents the results from the RIA analysis, showing that
corticosterone levels in arsenic offspring were higher than controls by
approximately a 2-fold increase (t(9) = 2.491; p = 0.03).

2.4.3 CRFR1 Receptor Protein
Figure 2.2A illustrates a representative Western blot analysis of hippocampal
CRFR1 receptor protein in whole hippocampal homogenates from arsenicexposed and control offspring. As shown in Figure 2.2A, the optical densities of
the bands from the arsenic-exposed mice were lower than the controls.

A

summary of the Western blot data is provided in Figure 2.2B. Perinatal arsenic
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exposure significantly reduced the quantity of CRFR1 receptor protein by
approximately 32% in hippocampal formation compared to the control water
group (33 +/- 1.8 for control vs. 22 +/- 1.8 for arsenic samples). Asterisk denotes
data significantly different compared to the control water group (t (22) = 3.64,
p<0.001).

2.4.4 Specific [3H]-DPAT Binding and DPAT-stimulated [35S]-GTPγS Binding
Figures 2.3 and 2.4 illustrate representative autoradiograms depicting the
distribution of total and non-specific [3H]-DPAT binding to 5HT1A receptors
(panels A & B) and 2 μM DPAT-stimulated and basal [35S]-GTPγS binding
(panels C & D) in coronal and horizontal sections from the brain of an untreated
control mouse. Total [3H]-DPAT binding site densities were highest in the
hippocampal formation and cortical brain regions (Figures 2.3A & 2.4A). The
distribution of DPAT-stimulated [35S]-GTPγS binding (Figures 2.3C & 2.4C) was
similar to the distribution of [3H]-DPAT binding (Figures 2.3A & 2.4A).
The effects of perinatal arsenic exposure on specific [3H]-DPAT binding, basal
and DPAT-stimulated [35S]-GTPγS binding in adult offspring are summarized in
Figure 2.5.

Specific [3H]-DPAT binding was significantly increased by

approximately 77% in the dorsal hippocampal formation of arsenic-exposed mice
(0.57 +/-0.06) compared to the control group (0.31+/- 0.05) (Figure 2.5A). In
contrast, specific [3H]-DPAT binding was not different in the ventral hippocampal
formation, the parietal cortex, entorhinal cortex or the inferior colliculus. Basal
[35S]-GTPγS binding was not different in any of the brain regions measured
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(Figure 2.5B). In the presence of a half-maximally effective (EC50) concentration
of DPAT (2 μM) dorsal hippocampal DPAT-stimulated [35S]-GTPγS binding was
64% greater in arsenic-exposed offspring (0.35 +/-0.07) than control (0.23 +/0.03) (Figure 2.5C). Asterisks denote data significantly increased compared to
the untreated control group (multivariate, one-way ANOVA F(1,12)=9.8 p<0.001
in Figure 2.5A; F(1,10)=6.6 p<0.03 in Figure 2.5C). As was the case for specific
[3H]-DPAT binding (Figure 2.5A), 2 µM DPAT-stimulated [35S]-GTPγS binding
was not different between the two groups in the other four brain regions
examined (Figure 2.5C). In the presence of a maximally effective concentration
of DPAT (20 μM), DPAT-stimulated [35S]-GTPγS binding was not different in any
of the five brain regions examined (Figure 2.5D).

2.4.5 Learned Helplessness Task
Perinatal arsenic exposure produced a significant increase in escape latencies in
both male and female adult mice (Figure 2.6). There was a significant effect of
learned helplessness training (F(1,40) = 783, p<0.0001), an effect of perinatal
arsenic (F(1,40) = 194 p<0.0001) and an interaction between perinatal treatment
and learned helplessness training (F(1,40)= 63.6 p<0.001). No differences were
observed between the groups in a pain threshold test measuring vocal response
to footshock intensity (data not shown).
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2.4.6 Forced Swim Task
Perinatal arsenic exposure produced a significant increase in immobility in
exposed mice compared to controls (Figure 2.7). There was a significant effect of
arsenic on immobility t(14)=8.14, p<0.001.

2.5 DISCUSSION
The present findings demonstrate that perinatal exposure to relatively low levels
(50 ppb) of arsenic in drinking water can have long-lasting biochemical and
behavioral effects on adult offspring. Perhaps the most striking effect observed
in these studies was the impact of perinatal arsenic exposure on plasma
corticosterone (Figure 2.1) which was assessed under baseline, non-stressed
circumstances (Figure 2.1).

Qualitatively similar elevations in corticosterone

levels have been noted also in perinatal lead-exposed rats (Cory-Slechta et al,
2008).

Increased serum corticosterone levels suggest that the HPA axis is

overactive in these arsenic-exposed offspring.
While it is not possible to discern from these experiments whether elevated
plasma corticosterone is a primary teratogenic effect of perinatal arsenic
exposure or a secondary, perhaps compensatory consequence of effects on
systems that regulate the HPA axis, it is noteworthy that the other biochemical
alterations (Figures 2.1, 2.2, 2.5) and behavioral effects (Figures 2.6, 2.7)
observed in these studies are consistent with sustained elevations in HPA axis
activity.

For example, perinatal arsenic exposure decreased hippocampal

CRFR1 levels compared to controls (Figure 2.2). While hippocampal CRF levels
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were not measured in this study, it is reasonable to speculate that if CRF levels
are elevated to a similar degree as plasma corticosterone (Figure 2.1), the
decrease in hippocampal CRFR1 in the perinatal arsenic mice may represent a
compensatory down-regulation in response to heightened CRF activation.
Several studies have reported increased CRF in response to intense or
prolonged stress. Four hours of restraint stress in mice resulted in a significant
increase of CRF mRNA expression within the paraventricular nucleus (Nomura et
al., 2003) and similar increases in CRF were seen using in an earlier study using
crowded rearing conditions as a stressor (Albeck et al., 1997) in rats.
Perinatal arsenic exposure elevated specific [3H]-DPAT binding to 5HT1A
receptors (Figure 2.5A) in dorsal hippocampal formation. This study utilized a
[3H]-DPAT concentration near the half-maximally saturating (Kd) concentration
(Hensler et al., 1991). This effect of perinatal arsenic exposure on specific [3H]DPAT binding was accompanied by increased DPAT-stimulated [35S]-GTPγS
binding at a half-maximally effective concentration of agonist (Figure 2.5C), but
not at a saturating concentration of the agonist (Figure 2.5D). Taken together,
these data suggest that perinatal arsenic exposure increases the sensitivity of
dorsal hippocampal 5HT1A receptors to serotonin without altering the total
number of receptors present. Further, these results suggest that basal [35S]GTPγS binding (Figure 2.5B) and 5HT1A receptor-effector coupling were not
affected in perinatal arsenic exposed offspring.

More detailed saturation of

specific [3H]-DPAT binding and DPAT-stimulated [35S]-GTPγS binding would be
required to substantiate this interpretation. However, the inability to collect an
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adequate number of histological sections in specific regions of mouse brain limits
more extensive saturation of binding studies.
It is noteworthy that elevations in 5HT1A receptor sensitivity were not observed in
other brain regions (Figure 2.5A and 2.5C) and were observed only in the dorsal
hippocampal formation. This suggests that the hippocampal formation is at least
one of the brain regions most susceptible to the consequences of perinatal
arsenic exposure.

Further, while differences between the dorsal and ventral

hippocampal formation have been identified (see Moser and Moser, 1998), the
basis for differential dorsal-ventral hippocampal sensitivity in arsenic-exposed
mice is not known. However, qualitatively similar outcomes have been observed
in the study of hippocampal glutamate receptors in prenatal ethanol-exposed
offspring (Farr et al., 1988; Savage et al., 1991). The mechanistic basis for
elevated 5HT1A receptor sensitivity in perinatal arsenic-exposed mice is not
known.

Chronic elevated HPA axis activity that has been associated with

diminished firing of raphe serotonergic neurons and a reduction in serotonin
turnover and release (Davis et al., 1995; Myint et al., 2007), including a decrease
in 5HT1A mRNA following 20 days of chronic unpredicted footshock stress (Xu et
al., 2007) and decrease in 5HT1A activity in the dorsal raphe, following chronic
social defeat stress (Cornelisse et al., 2007). Thus, in our study a diminished
serotonergic activity following the chronic elevation of corticosterone produced by
perinatal arsenic may have resulted in a compensatory up-regulation of 5HT1A
receptor sensitivity in the hippocampus.
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The effects of perinatal arsenic exposure on biochemical measures associated
with depression were accompanied by alterations in two measures of depressivelike behaviors, learned helplessness and immobility during forced swim. Both
male and female perinatal arsenic-exposed mice displayed greater learned
helplessness behavior following inescapable shock exposure (Figure 2.6). No
gender effects were noted between groups. Forced swim task data (Figure 2.7)
revealed that arsenic-exposed animals show more immobility, which is indicative
of depressive-like behavior. These data suggest an increased susceptibility to
depression and are consistent with human studies suggesting that elevated
cortisol in response to chronic stress is associated with increased depressive
symptoms (see Southwick et al., 2005 for review). While perinatal arsenic may
not be considered a typical stressor, our data suggest that the prolonged
elevation of corticosterone produced by perinatal arsenic may have produced
physiological state mimicking chronic stress.
While there are no studies directly demonstrating arsenic induced 5HT1A receptor
changes, arsenic does interfere with glucocorticoid signaling pathways (Stancato
et al., 1993; Kaltreider et al., 2001; Bodwell et al., 2004) which, in turn, affect
serotonin neurotransmission, acute stress increasing activity and chronic stress
attenuating activity (Meijer and DeKloet, 1998). Arsenic directly interferes with
the glucocorticoid receptor complex and inhibits steroid binding to glucocorticoid
receptors (Simons et al., 1990). Our model suggests that this would prevent the
normal operation of the negative feedback mechanism, increasing plasma
corticosterone levels, a phenomenon we observed. We also observed lower
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levels of CRFR1 in the perinatal arsenic-exposed animals, perhaps as a
compensatory response to elevated CRF. Lower activity by CRFR1 would
attenuate serotonin release in the hippocampus (Oshima et al., 2003) resulting in
a compensatory increase in 5HT1A receptor affinity.
Previous research has outlined a role for 5-HT1A receptor in antidepressant
response.

Patients who respond to antidepressant treatment require a

desensitization of 5-HT1A receptor (Rausch et al., 2006). Studies also suggest
that a polymorphism in the 5-HT1A gene resulting in non-repression of the
receptor has been associated with poor response to antidepressant therapy in
unipolar and bipolar subjects (Lemonde et al., 2004; Serretti et al., 2004). Further
evidence suggests that there is an increased expression of the 5-HT1A receptor
and mRNA in brains of suicide victims (Escriba et al., 2004). Recently, it has
been suggested that an alteration of the hippocampal function may be involved in
the etiology of depression (Warner-Schmidt and Duman, 2006) and that changes
in the hippocampal serotonergic system are, in part, responsible for its
pathogenesis (Iritani et al., 2006). All of the previous research on serotonin ties
into our depressive-like behavioral analysis of perinatal arsenic-exposed mice.
Finally, a negative impact of perinatal arsenic on learning has previously been
reported (Rodriguez et al. 2002). In a study using rats, they showed perinatal
exposure to arsenate (36.70 mg/L in drinking water) from gestation day 15 (GD
15) resulted in increased spontaneous locomotor activity and an increased
number of errors in a delayed alternation task in comparison to the control group
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(Rodriguez et al., 2002).

Although we are studying a mouse model, it is

important to note that the whole body retention of inorganic arsenic in rats has
been shown to be 20 times higher than that in similarly exposed mice due to
retention of arsenic in erythrocytes, (Vahter, 1981) therefore the arsenic effects
observed in our mouse model are at a dose that is much lower than those used
in the Rodriguez study. Also, the Rodriguez study dosing schedule occurs at
GD15 suggesting that effects we have seen at lower doses may be taking place
during the embryonic stages when the brain is forming. One alternative
interpretation of our data is that failure to escape in the learned helplessness task
may be due to arsenic-induced deficits in learning and memory, and not an
indication of increased depressive-like behavior.

While this is possible, the

arsenic animals failed to demonstrate escape-directed behaviors in the forced
swim task which is not dependent upon learning or memory to perform. Further,
there were no differences in non-shock escape latencies in the non-shock control
groups between the two perinatal exposure conditions in either male or female
mice (data not shown).

These results suggest that the perinatal arsenic-

exposure did not affect the ability to escape in the absence of learned
helplessness training. Thus, while arsenic has been demonstrated to produce
deficits in learning performance, the deficits in learned helplessness seen in our
study were not the result of an inability to perform the task or to understand
association between escape and the termination of the foot shock since the
perinatal arsenic-exposed mice were as successful as control mice in escaping
the shock in the non-shocked control condition.
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These results demonstrate that there are neurochemical and behavioral
consequences of heavy metal exposure during brain development. The perinatal
period encompasses the key developmental periods in most species. Synaptic
organization, which sets up functional development of neurotransmitter and
neuromodulatory systems, is occurring during this time. This period is critical
because it influences how the animals will respond to their external environment
throughout their lives. Administration of toxins during this critical period can have
lifelong consequences due to their deleterious effects during major brain
maturation periods. Future research should aim to address the consequences of
arsenic in the developing CNS.
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2.7 TABLES
Table 1. Effects of perinatal exposure to 50 parts per billion arsenic in
drinking water on litter size and offspring body weight on postnatal day 7.
# of Litters

Litter Sizea

Body Weightb

Control

8

6.0 + 0.78

4.66 + 0.39

Sodium Arsenate

9

4.6 + 0.86

4.29 + 0.46

Experimental
Group

a – Mean + S.E.M. number of pups per litter
b – Mean + S.E.M. pup body weight in grams
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Plasma Corticosterone (ng/mL)
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Figure 2.1 The effect of perinatal arsenic exposure on plasma
corticosterone levels.
Data bars represent the mean + SEM nanograms corticosterone per mL plasma
from five or six mice per perinatal treatment group.

Asterisk denotes data

significantly elevated compared to the control water group (two-tailed t-test, t(9) =
2.491, p = 0.03).
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Figure 2.2 The effect of perinatal arsenic exposure on hippocampal CRF
receptor protein levels in adult offspring.
A:

Representative immunoblots of triplicate control and arsenic-exposed

samples and a standard curve. B: Data expressed as immunoreactivity units
calculated from a protein standard curve using control hippocampal tissue. Data
bars represent the mean + SEM of 12 mice in each perinatal treatment group.
Beta-actin was used as a loading control. Asterisk denotes data significantly
different compared to the control water group (t (22) = 3.64, p<0.001).
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[3H]-DPAT Binding
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[35S]-GTPγS Binding

C.

D.

Figure 2.3 Autoradiograms of [3H]-DPAT binding and DPAT-stimulated
[35S]-GTPγS binding in coronal sections of brain from an untreated control
mouse.
A: Total [3H]-DPAT binding. B: Non-specific [3H]-DPAT binding (binding in the
presence of 20 μM unlabelled DPAT). C: [35S]-GTPγS binding in the presence of
2 μM DPAT. D: Basal [35S]-GTPγS binding (binding in the absence of added
DPAT).

Binding measurements were made in the dorsal hippocampal CA1

stratum radiatum and the parietal cortex (Layers 1-3) immediately dorsal to the
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hippocampal formation. The horizontal bar at the bottom of panel D denotes a
distance of 1 mm.
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Figure 2.4 Autoradiograms of [3H]-DPAT binding and DPAT-stimulated
[35S]-GTPγS binding in horizontal sections of brain from an untreated
control mouse.
A: Total [3H]-DPAT binding. B: Non-specific [3H]-DPAT binding (binding in the
presence of 20 μM unlabelled DPAT). C: [35S]-GTPγS binding in the presence of
2 μM DPAT. D: Basal [35S]-GTPγS binding (in the absence of added DPAT).
Binding measurements were made in the ventral hippocampal CA1 stratum
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radiatum, medial entorhinal cortex, (Layers 1-3) and the inferior colliculus. The
horizontal bar at the bottom of panel D denotes a distance of 1 mm.
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binding. Data bars represent the mean + SEM of 5 to 11 mice in each group.
Asterisks denote data significantly increased compared to the untreated control
group (multivariate, one-way ANOVA F(1,12)=9.8 p<0.001 in Figure 5A;
F(1,10)=6.6 p<0.03 in Figure 5C).
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Figure 2.5 The effects of perinatal arsenic exposure on 5HT1A receptor
density and 5HT1A receptor-effector coupling in five regions of adult mouse
brain.
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Figure 2.6 The effect of perinatal arsenic exposure on learned helplessness
in adult male and female offspring.
Data bars represent the mean + the SEM of five mice in each group. Asterisks
denote significant differences between control and arsenic-exposed offspring. A
two-way ANOVA was performed with a t-test as a post-hoc. There was a
significant effect of learned helplessness training (F(1,40) = 783, p<0.0001), an
effect of perinatal arsenic F(1,40) = 194 p<0.0001 and an interaction between
perinatal treatment and learned helplessness training F(1,40)= 63.6 p<0.001.
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Figure 2.7 The effect of perinatal arsenic exposure on forced swim task in
adult offspring.
Data bars represent the mean ± the SEM of eight mice in each group. Asterisks
denote a significant elevation in time spent in immobile behaviors compared to
the control water group (two-tailed t-test, t(14) = 8.11, p < 0.001).
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3.1 ABSTRACT
Most studies on arsenic as a drinking water contaminant have focused on its
carcinogenic potential but a few suggest that arsenic can adversely affect
cognitive development. One parameter of the hypothalamic-pituitary-adrenal
axis, the corticosterone receptor (CR) has been shown to be altered by arsenic.
These receptors are found throughout the central nervous system, particularly in
the hippocampus, an area of the brain of central importance for learning and
memory. We examined the impact of perinatal exposure to 50 parts per billion
(ppb) sodium arsenate on CRs and learning and memory behavior in the
C57BL6/J mouse. Measurements of CRs revealed that arsenic-exposed offspring
have significantly lower levels of both glucocorticoid and mineralocorticoid
receptors in the nuclear subcellular fractions than controls. Exposed offspring
showed longer latency to approach a novel object than controls in an object
recognition task. In the 8-Way Radial Arm Maze, arsenic offspring had a
significant increase in the number of entry errors on the task compared to
controls. Results suggest that moderate exposures to perinatal arsenic can
significantly reduce CR levels in the hippocampus and can have adverse effects
on learning and memory behavior. While these studies in themselves do not
provide a direct link between the learning deficits and the alterations in the HPA
axis, in context with previous work on stress and learning they suggest that
damage to the HPA axis by perinatal arsenic could lead to learning deficits.
Overall, this data suggests that moderate levels of perinatal arsenic can have a
lasting impact on offspring.
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3.2 INTRODUCTION
Arsenic is one of the most toxic naturally occurring contaminants found in the
environment.

A common source of human exposure to inorganic arsenic is

through drinking water contamination. Exposure has been associated with skin,
lung and bladder cancers, vascular diseases, hypertension, genotoxicity, cellular
disruption and diabetes (ATSDR Arsenic, 2007). While most studies on arsenic
have focused on its carcinogenic potential, studies in rodents pioneered by
Rodriguez and colleagues suggest that arsenic can adversely affect cognitive
development (Rodriguez et al., 2001, 2002), however, these effects on nervous
system development and function have received less attention (Rodriguez et al.,
2003). Literature describing the effects of arsenic in drinking water on human
cognitive development is sparse, and has been best characterized through
epidemiological studies, often based on research from countries with significantly
higher arsenic concentrations than the United States (Calderon et al., 2001; von
Ehrenstein et al., 2007; Wasserman et al., 2004). The majority of these studies
have focused on children; and deficits in learning and memory, particularly in
hippocampal-dependent tasks, following acute and chronic arsenic exposure
have been reported. However, the cellular and molecular mechanisms involved
in this process are still poorly understood.
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Events that disrupt maturation and development of the hypothalamic-pituitaryadrenal (HPA) stress axis have been shown to permanently alter CR expression
in the adult (de Kloet et al., 1998; Matthews et al., 2000; Welberg and Seckl,
2001). CRs are found in heterooligomeric complexes in the cytoplasm and upon
binding corticosterone (CORT) are translocated to the nucleus where they
influence diverse gene transcription. The glucocorticoid receptor (GR) and the
mineralocorticoid receptor (MR) are two forms of the CR which are activated by
binding of CORT. Arsenic has been shown to perturb components of the HPA
stress axis, like the GR (Bodwell et al., 2004) and alter gene expression of
inducible genes (Hamilton et al., 1998). Perturbation of the HPA stress axis has
been implicated in both cognitive damage and the promotion of carcinogenesis.
Thus far, no studies of the effects of perinatal arsenic on GR and MR have been
reported.
Neurons in the hippocampus contain both GRs and MRs. GRs are involved in
consolidation of learned information (de Kloet et al., 1999) and MRs involved in
interpretation of novel information (Berger et al., 2006), memory retrieval (Conrad
et al., 1997), and visuospatial learning (Yau et al., 1999). Further, spatial learning
and memory deficits have been shown in GR and MR knockout mice (Berger et
al., 2006; Steckler et al., 1998) and sustained activation of GR by chronically
elevated CORT impairs hippocampal function and memory processes (McEwen
and Sapolsky, 1995). The connection between the hippocampus and learning
and memory has been well established for decades. De Kloet and colleagues
(1998) showed that both the presence of CORT and a functional GR are critical
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to normal hippocampal function. Stress, through the actions of CORT and CRs,
can either facilitate or impair learning and memory processes (Joels, 2006).
Studies have shown that, at intermediate levels, CORT enhances learning and
memory but low or high levels adversely affect cognition (Lupien and McEwen,
1997). We have previously shown that perinatal arsenic-exposed offspring have
elevated levels of circulating CORT into adolescence and young adulthood
(Martinez et al., 2008). Evidence from prenatal lead exposure studies suggest
that excess fetal CORT levels can program pathologies in adult life (Cory-Slecta,
2004; Seckl and Meaney, 2004). High levels of circulating CORT have been
frequently shown to be associated with a series of clinical diseases including
neurodegenerative diseases, major depression and schizophrenia as well as
aging (Alderson and Novack, 2002; Belanoff et al., 2001; Lupien et al., 1999).
Given our previous report of high basal CORT levels in perinatal arsenic-exposed
offspring (Martinez et al., 2008), we examined hippocampal GR and MR
translocation to determine if this parameter was affected by the arsenic-induced
changes in CORT level. We also examined spatial and non-spatial learning and
memory behavior in our perinatal mouse model to determine if deficits were
attributable to the role of glucocorticoids.

3.3 METHODS
Note: Arsenic is classified as a probable human carcinogen (ATSDR, 2007). All
arsenicals were handled as potentially highly toxic compounds.
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3.3.1 Perinatal Arsenic Exposure Paradigm
The arsenic exposure paradigm and behavioral tasks employed in these studies
were approved by the UNM Health Sciences Center Institutional Animal Care
and Use Committee. All mice were bred and maintained on a reversed 12-h
light/dark cycle (lights on from 17:00 to 09:00h) with food and water ad libitum in
a temperature controlled (22ºC) room in the Animal Resource Facility. All dosing
suspensions were prepared approximately weekly. Arsenic water (sodium
arsenate, Sigma, St. Louis, MO) was prepared using standard tap water. Control
mice were administered untreated tap water. Tap water at UNM contains
approximately 5 ppb arsenic. Female C57BL/6J mice (Jackson Laboratories, Bar
Harbor, ME) were assigned to either a control or 55 ppb arsenic water treatment
group. After a 2-week acclimation period on the treated waters, male breeder
mice were introduced into each female’s cage. Three days later, the males were
removed from the cages and nesting material was placed in the female’s cage.
Mouse dam water consumption was monitored throughout pregnancy and the
dams continued to drink the treated waters until their offspring were weaned.
Offspring were weaned at 23 days of age and maintained in same-sex, littermate housed cages with ad libitum access to untreated tap water and mouse
chow (7004 Harlan Teklad S-2335, Denver, CO) until they were used in
experimental procedures at 35-40 days of age. Mice (two per litter; 5-10 litters
total per treatment group) were assigned to either one of the biochemical assay
procedures or the behavioral testing methods. Offspring used in behavioral
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studies were not used in biochemical studies. A sample size of five represents
the total number of litters and not individual animals used.

3.3.2 Drinking Water Analysis and Data
Arsenic and control water bottles were monitored and recorded every other day
for water consumption. Bottles from individual cages were weighed to the nearest
tenth of a gram. Water samples (10mL) from each dosing suspension were sent
in their liquid forms to the laboratory of Dr. Abdul-Mehdi Ali (UNM Department of
Earth and Planetary Sciences) for determination of arsenic concentration
according to US EPA method 200.8.

3.3.3 Offspring whole brain arsenic concentrations
To evaluate whole brain concentrations of arsenic, samples were analyzed using
Inductively Coupled Plasma-Mass Spectrometry (ICP-MS, Perkin Elmer Elan
DRC II, Waltham, MA) by Dr. Ali. The internal standard was Indium (In) at mass
115. The analysis was performed comparable to method US EPA 200.8. Exactly
10 mL of the standards, samples, and QC samples were spiked with 1 mL of 100
mg/L Indium (In) as internal standard to correct for drifts in the signal that may be
caused by sample matrix, viscosity, and/or peristaltic pump (sample) pulsing. The
system was calibrated using NIST traceable calibration standards (stock solution)
and QC solutions (stock solution). The system is sensitive down to the parts per
trillion level. Three mg brain samples were taken from one cerebellar lobe from
arsenic-exposed and control mice. Samples were digested, using 2 mL nitric
acid, at 90oC. After digestion was completed, digests were brought up to 10 mL
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final volume and transferred into Inductively Coupled Plasma (ICP) plastic tubes.
Results were then calculated using the starting weight and the final volume after
digestion. Results were expressed as ug/g and then converted to ppb based on
the standard curve. Samples were run in duplicate.

3.3.4 Western Immunoblotting
3.3.5 Tissue Preparation
Adolescent offspring, 35-40 days of age, were sacrificed by decapitation and
whole hippocampal formation rapidly dissected. Subcellular fractions are
prepared exactly as described by Buckley et al. (2004). Protein determinations
were performed as described in Weeber et al. (2001) and were used to load
equal amounts of protein in each well. To determine the lack of cytoplasmic
contamination in the nuclear fraction, the membrane was probed between 68kDa
and 21 kDa for anti-A-Raf (1:500; Santa Cruz) and anti-H-Ras (1:500; Santa
Cruz) antibodies, respectively.

3.3.6 Glucocorticoid and Mineralocorticoid Receptors
Cytosolic and nuclear fractions from seven or eight hippocampi from arsenicexposed and control animals were analyzed for GR and MR via western blot. The
linear range of the total protein was calculated to ensure that the protein was not
saturating the blot (data not shown). Control samples were run on the same blot
as arsenic-exposed samples. The amount of total GR and MR of the sample was
corrected for Beta-actin and data analyzed by t-test. Extracts were thawed on
ice, diluted in 4X SDS-PAGE sample buffer (Invitrogen, Carlsbad, CA) and
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heated at 70oC for 10 minutes. Samples (2ug protein per well (GR); 3ug protein
per well (MR)) were separated using 4-12% NuPAGE Bis-Tris gels (Invitrogen)
and transferred to 0.45-um-thick nitrocellulose membranes (Invitrogen). The GR
and MR membranes were blocked with 0.25% I-block (Applied Biosystems,
Foster City, CA) in TBS-T (25mM Tris-HCl pH 7.2, 150mM NaCl and 0.05%
Tween-20) for one hour at room temperature. Blots were then cut and incubated
with either a polyclonal primary antibody to GR (1:3 000; M-20, Santa Cruz
Biotechnology, Santa Cruz, CA), MR (1:500; H-300 Santa Cruz) or B-actin (1:2
000; Cell Signaling, Boston, MA) overnight at 4oC. The reaction was stopped
with four consecutive 5-minute washes in TBS-T. A goat anti-rabbit IgG
(H+L):HRP (1:50 000, Thermo Fisher Scientific, Rockford, IL) was used for the
secondary antibody incubation in 0.25% I-block one hour at room temperature.
The reaction was stopped with four consecutive 5-minute washes in TBS-T.
Membranes were then incubated in Supersignal West Pico Working Solution
(Thermo Scientific) for five minutes and exposed to F-BX57 film (Phenix
Research Products, Candler, NC). Film was developed in Kodak D-19 developer
then washed and fixed in Kodak fixer. The developed film was scanned (Hewlett
Packard Scan Jet 5P) and immunoreactivities quantified by measurements of
optical densities using BioRad Quantity-One analysis software. Each protein
sample was run in duplicate and the average optical density taken.

3.3.7 Novel Object Exploration
The novel object exploration task was conducted in a plexiglas open field
apparatus (43 cm x 43 cm x 21 cm high, designed by Allan laboratory) using a
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protocol described previously by Grailhe et al. (1999). The floor of the apparatus
was black and divided into five areas: Four equal quadrants and one center area
14 cm. in diameter. The experiments were conducted in a dimly lit room with the
aid of a video camera to minimize subject stress and anxiety. The floor and walls
of the open field were wiped with 70% isopropanol before each test session.
Each test consisted of two videotaped five-minute sessions. During the first
session, mice were placed in the center area and allowed to explore and
acclimate to the apparatus. A novel object, consisting of a pink and green striped
gray cube (2.5 cm3) with an open side (designed by Allan laboratory), was
placed in the center area with the open side facing the mouse. Response to the
novel object during the second five minute session was videotaped.
Subsequently, a trained observer blinded to experimental group identity analyzed
the video tapes and measured latency to approach the object and total number of
center line crosses in the presence of the novel object.

3.3.8 Eight-way Radial Arm Maze
Radial arm maze testing was conducted using the mouse runway system from
Coulbourn Instruments (Whitehall, PA) using a protocol modified from Egashira
et al. (2002).

Plastic food cups containing sweetened condensed milk as a

reinforcer, were placed approximately 2/3rds the way down in each arm. The
maze was located in a room containing many extra-maze visual cues. Arm entry
was recorded by an observer seated several feet away from the maze. All mice
were habituated to the maze for 20 minutes on the day prior to testing. One week
before testing, mice were placed on a caloric restriction diet where they received
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3 grams of lab chow (7004 Harlan Teklad S-2335, Denver, CO) each day.
Untreated tap water was available ad libitum. Testing was conducted over 3
consecutive days. For each 8 minute testing session, the mouse was placed in
the center of the maze. For each testing session; the number of correct choices
in the initial eight chosen arms and the number of errors which was defined as
choosing arms which had already been visited were scored.

3.3.9 Statistical analysis
All data were analyzed by t-test comparing the perinatal arsenic to the control on
each of the dependent measures. Unless otherwise noted, all behavioral data
points were taken from two animals per litter and this average treated as a single
result. A repeated measures ANOVA was used in the eight-way radial arm maze
behavioral test. Significance was set at p ≤ 0.05.

3.4 RESULTS
3.4.1 Arsenic Exposure Paradigm
No signs of overt toxicity (i.e. ataxia, redness, swelling, fetal malformations,
death) were observed in the mice throughout the duration of the study. Absence
of structural malformations is in accordance with what has been shown
previously (Holson et al., 2000). The doses of arsenic used in present study were
well tolerated and did not alter maternal body weight or body weights of the
newborn pups (Martinez et al., 2008), consistent with what has been reported by
others (Bardullas et al., 2009). Arsenic exposure did not change whole brain
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weight (t<1, not significant) or hippocampal wet weight (t<1, not significant) of
offspring at Day 35.

3.4.2 Drinking Water Analysis and Data
Samples from six arsenic treated and six control water samples from throughout
the span of the study were sent to Earth and Planetary Sciences for analysis.
Water arsenic concentrations, analyzed by ICP-MS, were ~56 ppb and untreated
tap water (control group) concentrations were ~6 ppb. The average daily litter
water consumption, monitored every other day, and averaged over the entire
study period was 13.09 ± 0.93 grams/day for the control group and 15.98 ± 2.97
grams/day for the perinatal arsenic group. There were no significant differences
in the amount of water consumed by the litters in either treatment condition (t<1,
not significant). We did not measure the amount of arsenic present in mother’s
breast milk because this amount has been shown to be negligible according to
several papers. One example comes from a study of Andean women exposed to
high concentrations (about 200ppb) of inorganic arsenic in drinking water. The
concentrations of arsenic in their breast milk ranged from about 0.0008 to
0.008ppm (Concha et al., 1998). Similarly, a World Health Organization study
detected arsenic at concentrations of 0.00013-0.00082 ppm in human breast milk
(Somogyi and Beck, 1993). Although these studies were not conducted in
animals, extrapolation of the data would suggest that the concentration of arsenic
that is present in the breast milk in our mice after exposure to arsenic in their
drinking water is extremely low.
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3.4.3 Brain Arsenic Concentrations
Total inorganic arsenic concentrations detected in brain tissue of offspring at
35days of age were measured. Control brain levels were 1.0 ± 0.24 ppb and
perinatal arsenic offspring levels were 2.24 ± .02 ppb. Levels of arsenic in the
perinatal exposure group significantly exceeded controls (t(6) = 3.87, **p <
0.008). The source of arsenic in the brains of control animals may be either
organic or inorganic given that untreated tap water at UNM has ~6ppb arsenic
and approximate levels of arsenic within the chow are 0.16 ppm, based on
analyses done at Harlan Labs (personal communication).

3.4.4 Glucocorticoid and Mineralocorticoid Receptors
Due to the high basal CORT levels in the perinatal-exposed mice that we
previously reported (Martinez et al., 2008); we decided to examine the
intracellular distribution of the GR and MR proteins. Intracellular distribution of
the GR and MR is important for its function.
Figure 3.1, panels A-B and C-D, shows a representative western blot, together
with results of the densitometric quantitation of the nuclear and cytosolic
glucocorticoid receptor bands, respectively. The rabbit polyclonal antibody
against the mouse glucocorticoid receptor recognized a prominent band at
~95kD, consistent with the molecular weight of the glucocorticoid alpha receptor.
Perinatal arsenic exposure reduced levels of both nuclear and cytosolic GR
receptors. Figure 3.1B shows the quantification of the nuclear compartment
where there was significantly less GR in the perinatal mice than controls (t(13) =
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3.81, **p < 0.002). The cytosolic fraction (Figure 3.1D) revealed a similar
significance (t(13) = 2.11, *p < 0.05). This finding is curious as we would have
predicted higher nuclear GR levels in the perinatal offspring due to their higher
basal CORT levels.
Figure 3.2 shows a representative western blot, together with results of the
densitometric quantitation of the mineralocorticoid receptor bands. The rabbit
polyclonal antibody against the mouse mineralocorticoid receptor recognized a
prominent band at ~102kD, consistent with the molecular weight of the
mineralocorticoid receptor. In the perinatal arsenic exposed there was
significantly less MR in the nuclear fraction compared to controls (Figure 3.2B)
(t(13) = 5.95, ***p < 0.0001). Figure 3.2D shows the cytosolic fraction, where
there is no difference in relative amount of MR (t<1, not significant).

3.4.5 Novel Object Exploration
Behavior is an informative end-point for assessing the neurobiological effects of
arsenic exposure. Mineralocorticoid receptors have been shown to be associated
with ability to learn in a novel situation. We used the novel object task as a
measure of learning and memory. Figure 3.3, panels A and B, show the latency
to novel object and entries to center in presence of novel object, respectively
during a second five-minute period. Perinatal exposed mice took significantly
longer to recognize the presence of the novel object, measured as latency to
approach the novel object (t(12) = 13.79, ***p <0.0001). Compared to controls,
perinatal mice made significantly fewer center entries in the presence of the
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novel object (t(12) = 4.61, ***p < 0.0006). The increase in latency and center
entries may be confounded by an anxiety response; therefore we conducted an
additional behavioral test to rule out this variable.

3.4.6 Eight-way Radial Arm Maze
We used the 8-way radial arm maze to determine if the arsenic exposure was
associated with decreased hippocampal-dependent spatial learning and memory.
Because variations in maternal care within the same strain of animals can lead to
differences in behavioral performance including spatial memory (Barha et al.,
2007) we pulled offspring from different litters to preclude the litter effect. It has
also been reported that males inherently perform better on spatial memory tasks
than do females (Brandeis et al., 1989; Vorhees et al., 2004), thus only males
were used on the behavioral tasks. All mice were acclimated to the testing field
prior to test days. All control mice showed a progressive decline in number of
entry errors over the three testing days. Arsenic offspring errors did not change
significantly with test day (Figure 3.4). There was a significant effect of treatment
(F(1,18) = 50.79, ***p < 0.0001) and these results indicate that perinatal arsenic
exposure in mice might induce spatial-learning and memory impairment.

3.5 DISCUSSION
The persistence of arsenic in drinking water raises the importance of assessing
the neurobiological consequences of exposure to low levels of arsenic. Our
perinatal exposure model provides a unique opportunity to examine the effects of
arsenic on the developing brain at an environmentally relevant level, magnitudes
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lower than what has been previously studied. Arsenic has been shown to
accumulate in target organs (Kenyon et al., 2008) and at 35 days of age, two
weeks after weaning and absence of arsenic, our model revealed arsenic (total
arsenicals) content in the brains of our adolescent offspring. We are currently
seeking to determine which areas of the brain, if any, are preferentially affected.
We previously showed elevated basal CORT levels in offspring perinatally
exposed to 55ppb arsenic compared to their control counterparts (Martinez et al.,
2008). These findings led us to evaluate the status of the receptors responsible
for mediating changes in CORT levels. Results from the present experiments
revealed lower abundance of hippocampal cytosolic GRs in perinatal arsenicexposed offspring compared to controls but no difference in abundance of
cytosolic MRs. Nuclear levels of both GR and MR were significantly lower than
those of controls. In addition to this receptor deficit perinatal exposed mice
exhibited behavioral underperformance in the learning and memory tests.
CORT binds and activates the cytosolic GR and MR hormone receptors initiating
translocation of activated receptor to the nucleus. Although there is sufficient
CORT to activate these receptors in our animals (Martinez et al., 2008), the
amount of nuclear hippocampal GR and MR is significantly less in the arsenicexposed offspring than in the controls (figs. 3.1AB-3AB). A plausible explanation
for this is failure of the receptors to traffic to the nucleus. While other groups have
investigated this possibility and found that the trafficking of these receptors to the
nucleus is unaffected by arsenic (Kaltreider et al., 2001) these studies were
conducted using a hepatoma cell line and the results may not be the same in the
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brain, as is the case with many studies in other systems. In addition, the cell line
fails to maintain the contribution of the intact HPA axis and does not account for
genes that may have previously been affected. For example, high CORT levels
have been shown to reduce dynein cytosplasmic intermediate chain 1 gene
expression, reducing motor protein activity and axonal transport (Morsink et al.,
2006), a result that would not have been taken into account in the hepatoma cell
line. In accordance with our high CORT, the translocation of GR to the nucleus
by dynein may be reduced. Lower levels of nuclear GR and MR would have far
reaching consequences on gene transcription. It has been shown that, in
particular for GR, nuclear translocation of the activated receptor and its ability to
induce transcriptional activity are intimately correlated (de Kloet et al., 2009).
Binding of GRs to promoter glucocorticoid response elements (GREs) regulates
gene transcription both positively and negatively and approximately 20% of the
genome is under this control. In support of this possibility, we previously showed
increases in 5-HT1A receptor density in the dorsal hippocampus of our perinatal
arsenic-exposed mice (Martinez et al., 2008). The 5-HT1A receptor is negatively
regulated by corticosteroids through the GR (Chalmers et al., 1993; Datson et al.,
2001; de Kloet et al., 1986; Meijer et al., 1997) and reduced GR binding to
negative GREs would allow for transcription and ultimately upregulation of the 5HT1A gene and may be one example of the consequences of reduced nuclear
GRs.
The finding of no difference in cytosolic MR protein levels compared to controls
could be explained by the presence of two different promoters (P1 and P2) for
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the MR gene. P1 and P2 can both be activated by glucocorticoids but P2 can
also be activated by aldosterone with the same affinity (Viengchareun et al.,
2007). Thus GR and MR although both activated by glucocorticoids are also
differentially regulated. Activation of P2 by aldosterone, which is independent of
the HPA axis, could be enough to keep MR levels constant in the cytoplasm.
These differences in transcription regulation could help explain the differences in
protein levels seen in our animals.
The reductions in GR are important as studies using GR germline knockouts
have shown that knocking down the receptor in all organs results in an inviable
animal that dies approximately 1 week after birth due to atelectasis of the lungs
(Erdmann et al., 2008). However, conditional knockouts and loss of the receptor
in whole brain results in animals that are viable and exhibit many of the
characteristics that we have seen in our animals. For example, GR knockout
mice are reported to have elevated CORT levels, impaired spatial memory and
reduced anxiety behavior (Erdmann et al., 2008). Our perinatal arsenic-exposed
mice exhibit slight reductions in anxiety in the elevated plus maze (unpublished
observations) and depression-like behavior in a learned helplessness task
(Martinez et al., 2008). Dysregulation within the HPA axis has long been
suggested to be part of depressive pathophysiology. The high CORT levels at
the adolescent time point at which our measurements were taken suggests that
there is dysregulation of the axis. We are currently investigating this possibility.
GR expression is detectable at embryonic day 14.5 and HPA axis activity and
regulation is assumed to be established around this time during development
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(Michelsohn and Anderson, 1992). Our perinatal exposure period could be
affecting the establishment of regulation of the axis, enabling sustained or
cumulative damage with further high CORT levels resulting in an inability to
return to homeostasis and prevent a maladaptive overshoot. GRs are important
for terminating the stress response via negative-feedback control and MRs are
thought to control the basal circadian rhythm of plasma CORT secretion
(Sapolsky et al., 1986). A reduction in MRs and GRs, coupled with reduced
nuclear transport, could affect the maintenance of homeostasis via the HPA axis
and HPA response to stressful situations. Alterations in the HPA axis response to
stress and changes in transcription mediated by GR are likely to play an
important role in mechanisms underlying neural plasticity, providing a possible
basis for linking neuroendocrine dysregulation and cognitive decline.
It is well established that chronically elevated levels of CORT, mediated by the
binding to GRs and MRs, produce cognitive deficits (de Kloet et al., 2005, Joels
et al., 2007; McEwen, 2007). Many epidemiological studies have focused on the
issue of deficits in learning and memory associated with exposure to arsenic
(Calderon et al., 2001; von Ehrenstein et al., 2007; Wasserman et al., 2004). Our
perinatal arsenic-exposed offspring performed poorly on learning and memory
tests. Results from the novel object exploration test revealed deficits in latency to
the novel object and in number of center entries in perinatal-exposed animals
suggesting that arsenic animals have learning and memory deficits (fig. 3.3). This
impaired performance could be explained by loss of nuclear MR. Findings from
mutant mice with inactivated MR resulted in impaired behavioral reactivity to
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novelty (Berger et al., 2006). The 8-way Radial Arm Maze, an assessment of
spatial working memory, illustrated that arsenic-exposed offspring have
difficulties performing more arduous hippocampal-dependent learning tasks (fig.
3.4). Arsenic-exposed offspring failed to make improvements in the task as the
days progressed. This is in agreement with other findings that long periods of
stress or CORT treatment impair performance on a variety of spatial tasks
(Brinks et al., 2007; Elizalde et al., 2008; Schwabe et al., 2008). For example,
hypercorticism, after exposure to restraint stress for 6 hours per day for 3 weeks,
was shown to result in impaired spatial memory in adult animals (Conrad et al.,
1996; Luine et al., 1996). Furthermore, long-term high dose exogenous CORT
treatment in Long-Evans rats was shown to produce disruptive effects in watermaze performance, a test for spatial memory similar to the 8-way radial arm
maze (Bodnoff et al., 1995). MR appears to mediate the immediate effects of
CORT on memory acquisition, while presence of a functional GR is responsible
for modulation of spatial memory (Oitzl et al., 1997). While a direct link between
the poor performance in these behavioral tasks and reduced GR levels is not
established by these studies the findings are consistent with the interpretation
that memory performance is affected by arsenic-induced decreases in GR in the
hippocampus.
In conclusion, the present study indicates a relationship between
decreased CR levels and cognition. While other studies have examined CR
levels and subcellular localization in other target organs, to our knowledge ours is
the first report of the brain receptor levels after perinatal arsenic exposure.
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Changes in CR levels cannot fully explain the perinatal arsenic-induced
impairments in cognitive performance. However, these lower CR levels are likely
altering transcription of genes that are important for learning and memory.
Overall this data suggests that moderate perinatal arsenic exposure can have
long lasting effects on learning and memory well into adolescence, consistent
with the Fetal Basis of Adult Disease hypothesis (White et al., 2007), which
postulates that many adult diseases have a fetal origin. Further studies detailing
the molecular effects of perinatal arsenic exposure on the central nervous system
are essential to our understanding of arsenics production of learning and memory
deficits.

3.6 FUNDING
The project described was supported by Award Number F31ES017196
(E.J.M.F.) from the National Institute of Environmental Health Sciences, the
University of New Mexico Graduate and Professional Society-Graduate
Research Development Grant along with the legislature of the state of New
Mexico; the Pfizer Global Research and Development Safety Scholars
Fellowship and generous funds from the University of New Mexico College of
Pharmacy. The content is solely the responsibility of the authors and does not
necessarily represent the official views of the National Institute of Environmental
Health Sciences, the National Institutes of Health or Pfizer Global Research and
Development.

73

3.7 ACKNOWLEDGEMENTS
The authors thank David Leonard for technical support and Dr. Kevin Caldwell,
Dr. Laurie Hudson, Dr. Jim Liu, and Dr. Dan Savage for helpful discussions.

3.8 CONFLICTS OF INTEREST
The authors report no conflicting interests.

74

3.9 FIGURES
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Figure 3.1 Nucleocytoplasmic trafficking of GRs and densitometric
quantitation of GR bands.
(A) Representative western blot of GR in the hippocampal nuclear compartment
of arsenic exposed mice.

The anti-GR polyclonal antibody recognized a

prominent band at ~95kD, representative of GRα. (B) Quantitation of GR bands
in nuclear subcellular fraction of arsenic exposed mice was based on
densitometric analysis (**p < 0.002 vs. control). (C) Representative western blot
of GR in the hippocampal cytosolic compartment of arsenic exposed mice. (D)
Quantitation of GR bands in cytosolic subcellular fraction of arsenic exposed
mice was based on densitometric analysis (*p < 0.05 vs. control). Results are
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expressed as a percentage of the GR signal to B-actin signal, relative to controls
and are presented as mean ± SEM of seven-eight litters.
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Figure 3.2 Nucleocytoplasmic trafficking of MRs and densitometric
quantitation of MR bands.
(A) Representative western blot of MR in the nuclear compartment of arsenic
exposed mice. The anti-MR polyclonal antibody recognized a prominent band at
~102kD. (B) Quantitation of MR bands in hippocampal nuclear subcellular
fraction of arsenic exposed mice was based on densitometric analysis (***p <
0.0001 vs. control). (C) Representative western blot of MR in the cytosolic
compartment of arsenic exposed mice.
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(D) Quantitation of MR bands in

hippocampal cytosolic subcellular fraction of arsenic exposed mice was based on
densitometric analysis (p > 0.05 vs. control). Results are expressed as a
percentage of the MR signal to B-actin signal, relative to controls, and are
presented as mean ± SEM of six-eight litters.
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Figure 3.3 Effects of arsenic exposure to 50ppb arsenic on novel object
exploration at D35.
(A) Latency to approach novel object after acclimation period (***p <0.0001 vs.
control). (B) Entries to center in the presence of the novel object (***p < 0.0006
vs. control). Data are presented as mean ± SEM of seven litters.

77

Number of Entry Errors

Control
Arsenic

20
15
10
5
0
0

1

2

3

4

Day

Figure 3.4 Effects of arsenic-exposure on number of entry errors in 8-way
Radial Arm Maze at D35.
Day 1 represents first day after acclimation period. There was a significant effect
of treatment (***p < 0.0001 vs. control). Data are presented as mean ± SEM of
ten litters.
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4.1 ABSTRACT
Biosynthesis of members of the mitogen-activated protein kinase (MAPK)
signaling pathway, shown to be involved in learning and memory, are modulated
by glucocorticoid receptor (GR) binding glucocorticoid response elements
(GREs) in their promoters. We have previously reported increased basal plasma
levels of corticosterone, decreased hippocampal GR levels and deficits in
behavioral learning and memory performance in perinatal arsenic-exposed mice.
Two genes of the MAPK pathway, Ras and Raf, contain GREs which are
activated upon binding of GRs. Due to the lower levels of GRs in our mice we
evaluated the activity of GRs at Ras and Raf promoters via chromatin
immunoprecipitation and real-time PCR. In the present study we report
decreased binding of GR at these promoters which coincided with decreased
mRNA levels of both of these genes in perinatal arsenic-exposed mice. We also
investigated the role of extracellular-signal regulated kinase (ERK), a
downstream target of Ras and Raf, whose transcriptional targets also play an
important role in learning and memory. Nuclear activated ERK levels were
decreased in the hippocampus of arsenic-exposed animals compared to controls.
We performed electrophoretic mobility shift assay (EMSA) to assess the ability of
hippocampal

nuclear

GRs

to

bind

to

a

synthetic

radiolabeled

GRE

oligonucleotide. Interestingly, nuclear cellular fractions were capable of binding to
the GRE, although it is unclear whether or not GR is in this complex. GRmediated transcriptional deficits in MAPK/ERK pathway could be an underlying
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cause of the observed learning deficits and provide the link to arsenic-induced
deficiencies in cognitive development.
KEY WORDS
Arsenic,

Glucocorticoid

Receptor,

Glucocorticoid

Response

Element,

Extracellular-signal regulated kinase (ERK), Hippocampal formation, MAPK
Signaling Pathway, Raf, Ras

4.2 INTRODUCTION
The persistence of arsenic in the environment beckons the need for continued
research on arsenic and its health effects. Drinking water contamination is of
particular concern as arsenic has been shown to be permissive to a variety of
cancers, vascular diseases, and cellular disruption (Agency for Toxic Substances
and Disease Registry Arsenic, 2007). In addition, several studies have identified
arsenic as a potent neurotoxin and exposure poses a threat to cognitive
development in both rodents (Rodriguez, 2001; Martinez et al., 2008; MartinezFinley et al., 2009) and humans (Holson et al., 2000).
Moderate doses of arsenic have been shown to perturb glucocorticoid receptors
(GRs) (Kaltreider et al., 2001; Bodwell et al., 2006). We have shown that GR and
mineralocorticoid receptor (MR) protein levels in the hippocampus of brains of
offspring perinatally exposed to arsenic are significantly decreased compared to
age-matched controls at postnatal day 35 (Martinez-Finley et al., 2009). This is
consistent with what others have observed: events that disrupt maturation of the
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hypothalamic-pituitary-adrenal (HPA) axis, particularly during gestation, have
been shown to permanently alter glucocorticoid receptor (GR) expression in the
adult (Matthews, 2000; Welberg and Seckl, 2001). Increases and/or decreases in
transcription of genes under the control of GRs have been described as one
consequence of altered GR levels. In regards to arsenic, Kaltreider and
colleagues have shown that nontoxic doses of arsenite can interact directly with
GR complexes and selectively inhibit GR-mediated transcription (2001). At
concentrations between 1-3uM, the effects of arsenic on GR-mediated gene
activation are inhibitory (Bodwell et al., 2006). Hamilton and colleagues showed
that a single, low, non-overtly toxic dose of arsenite significantly altered basal
and inducible mRNA expression of the GRE-controlled phosphoenolpyruvate
carboxykinase gene in cell culture and in a whole-animal model (1998). They
also showed that arsenite had no effect on expression of GRE-non-inducible or
constitutively expressed genes (Hamilton et al., 1998). Given that GR controls
the transcription of a number of genes, the present work investigated the effects
of decreased levels of GR in the hippocampus on two genes shown to be
transcriptionally activated by GR.
Ras and Raf-1, two important members of the mitogen-activated protein kinase
(MAPK) signaling pathway are transcriptional targets of GR (Revest et al., 2005).
Ras and Raf-1 are core elements of the MAPK signaling pathway and their
activation ultimately leads to phosphorylation, activation and nuclear localization
of extracellular signal-regulated kinase (ERK1/2). The MAPK/ERK pathway plays
a crucial role in learning and memory (Sweatt, 2001; Sweatt, 2004). At the
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biochemical level, the MAPK pathway is linked to synaptic plasticity, which
contributes to memory formation and is important in information processing
(reviewed in Thomas and Huganir, 2004). Induction of long-term potentiation
(LTP), the best studied form of cellular learning and memory, relies on the
regulation of protein phosphorylation (reviewed in Thomas and Huganir, 2004)
and many forms of LTP have been shown to be ERK-dependent (English and
Sweatt, 1996; Atkins et al., 1998; Ohno et al., 2001). In addition to the decreased
levels of GR in the hippocampus, we have reported learning and memory deficits
in our perinatal arsenic-exposed offspring (Martinez-Finley et al., 2009). Because
the MAPK pathway has been implicated in learning and memory and GR has
been shown to transcriptionally regulate its members we evaluated this pathway
as a unifying factor for the effects that we have seen.
The present study focused on the connection between perinatal arsenic
exposure, decreased hippocampal GR and genes of the MAPK signaling
pathway in brains of exposed offspring as alterations in these cascades could
underlie the learning and memory deficits observed in these animals. We
investigated the binding association of nuclear GR with promoters in the Ras and
Raf-1 genes in hippocampal cells from our perinatal arsenic and control animals,
as well as GR association with a synthetic GRE. In addition, we assessed the
effects of decreased binding at these promoter sites by measuring mRNA levels
and activation of the downstream protein ERK.
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4.3 MATERIALS AND METHODS
Arsenic is classified as a probable human carcinogen and all arsenicals were
handled with extreme caution (ATSDR, 2007).

4.3.1 Perinatal Arsenic Exposure Paradigm
The arsenic exposure paradigm employed in these studies was approved by the
UNM Health Sciences Center Institutional Animal Care and Use Committee. All
mice were bred and maintained on a reversed 12-h light/dark cycle (lights on
from 21:00 to 09:00h) with food and water ad libitum in a temperature controlled
(220C) room in the Animal Resource Facility. All dosing suspensions were
prepared approximately weekly. Arsenic water (sodium arsenate, Sigma) was
prepared using standard tap water. Control mice were administered untreated
tap water. Tap water at UNM contains approximately 5 ppb arsenic. Mice were
bred according to our established protocol (Martinez et al., 2008; Martinez-Finley
et al., 2009). Offspring were weaned at 21 days of age and maintained in samesex, litter-mate housed cages with ad libitum access to untreated tap water and
standard mouse chow until they were used in experimental procedures at 35-40
days of age. A sample size of six (n = 6) represents the total number of litters and
not individual animals used.

4.3.2 Nuclear Extracts
Adolescent offspring, 35-40 days of age, were sacrificed by decapitation and
whole hippocampal formation rapidly dissected. Preparation of nuclear extracts
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and protein determinations were performed as described in Martinez-Finley et al
(2009).

4.3.3 Chromatin Immunoprecipitation (ChIP) Real-time PCR Assays
The protocol followed was a modified Upstate Biotechnology ChIP protocol as
described. Hippocampal tissue was collected and homogenized on ice in 1%
cross-linking solution (10% formaldehyde, 0.1M NaCl, 1 mM EDTA, 0.5 mM
EGTA, 50 mM Hepes pH 8.0 and double distilled H2O) for 15 minutes. Cells were
centrifuged at 1,000 x g at 4ºC for six minutes and washed five times with 1.5mL
PBS containing 1µL/mL protease inhibitor cocktail (Sigma, P8340). Cell pellets
were resuspended in cell lysis buffer (5mM PIPES pH8.0, 85mM KCl, 0.5% 2-[2(4-nonylphenoxy)ethoxy]ethanol(IGEPAL-CA-630)) and allowed to sit on ice for 5
minutes. The cells were then pelleted (1,000 x g at 4ºC for 6 minutes), cells were
resuspended in cell lysis buffer and repelleted. Cells were then resuspended in
nuclei lysis buffer (50mM Tris pH 8.1, 10mM EDTA, 1% SDS). At this point
samples were frozen in the -80ºC overnight. The following day, crosslinked DNA
was sheared via sonication (Kontes. Micro Ultrasonic Cell Disrupter; setting =
25%, four times 10 seconds, waiting a couple minutes between rounds) to
approximately 500-600 base pairs. To check the size of chromatin, 10µl of
sample was treated with 2µl of 10mg/ml proteinase K for 20 minutes at 50ºC to
reverse the cross-links. Sample was run on 1.5% (w/v) agarose gel. After brief
sonication to shear genomic DNA the samples were centrifuged (minimum of
10,000 x g but not exceeding 15,000 x g at 4ºC for 10 minutes). To prepare the
beads, swell protein G agarose (Sigma, P7700) in PBS (approximately 80µl
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settled beads per sample) and spin (1,000 x g at 4ºC for 1 minute) and
resuspend in blocking buffer (25µl 10mg/ml sonicated salmon sperm DNA,
100µL 1mg/ml BSA, q.s. to 1ml with H2O). Block 15 minutes at 4ºC rotating. The
mixture was then washed 2 times in 1.5 ml PBS and resuspended in 50/50 slurry
with ChIP dilution buffer. To preclean the cell lysate, 150µl of the supernatant of
cell lysate was diluted with 900µl ChIP dilution buffer (0.01% SDS, 1.1% Triton X100, 1.2mM EDTA, 16.7mM Tris pH 8.1, 167mM NaCl, 1µL/mL protease inhibitor
cocktail) and 80µl protein G slurry to eliminate nonspecific binding. Samples were
rotated at 4ºC for 1 hour, followed by pelleting of protein G (1,000 x g for 1
minute). Protein G was then discarded. A small fraction of the lysate (1%) was
then saved as “input DNA” (positive control). Input DNA was treated in parallel
with immunoprecipitated DNA during reverse crosslinking and purification steps.
After discarding the protein G, cell lysates were incubated with 5µg antiglucocorticoid receptor antibody (GR, M-20 Santa Cruz, sc-1004) or normal
rabbit IgG (Santa Cruz, sc-2027) as a negative control and rotated overnight at
4ºC. The following day 60µl of the 50/50 protein G agarose slurry was added and
samples were left to rotate for 2 hours at 4ºC. Protein G was then pelleted (1,000
x g for 1 min.), supernatant was discarded and sample was washed with 1.5ml of
ChIP Dilution buffer and rotated for 5 minutes at 4ºC. Sample was pelleted (1,000
x g for 1 min.). Wash step with ChIP dilution buffer was repeated. Next sample
was washed with 1.5ml TSE-500 (0.1% SDS, 1% Triton X-100, 2mM EDTA,
500mM NaCl) for 5 minutes and pelleted (1,000 x g for 1 min) and this wash was
repeated. Next the pellet was washed with 1.5ml LiCl/Detergent (100mM Tris pH
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8.1, 500mM LiCl, 1% IGEPAL, 1% deoxycholic acid) for 5 minutes and pelleted
(1,000 x g for 1 min) and this wash was repeated. Finally, the pellet was washed
in 1.5ml 1X TE, for 5 minutes and pelleted (1,000 x g for 1 min) and this wash
was repeated. The DNA was eluted from the beads with 250µl IP Elution Buffer
(50mM NaHCO3, 1% SDS). Samples were vortexed and left to rotate 15 minutes
at room temperature. Protein G was pelleted (3,000 x g for 5 min.) and
supernatant was saved. Elution step was repeated and elute was pooled.
Crosslinks were reversed overnight at 65ºC (20µl 5M NaCl). Saved input sample
received 460µl TE, 20µl 5M NaCl overnight at 65ºC. The following day samples
were incubated for 1 hour at 55-65ºC in 32µl (0.5M EDTA, 1M Tris pH6.5,
10mg/mL proteinase K) solution. DNA was isolated using Qiaquick Spin Columns
(Qiagen, 27104) according to manufacturers protocol and quantified by
NanoDrop® ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington,
DE). The ChampionCHIP One-Day Kit (SABiosciences) was also used according
to manufacturer’s instructions to confirm results. Purified DNA was used in PCR
amplification for 40 cycles using the Power SYBR green master mix (Applied
Biosystems, 4367659). The primers used for ChIP were based on sequences
published in Revest et al. (2005). Non-immune rabbit IgG was used to determine
non-specific antibody interactions and was subtracted from specific GR
interactions. Results are presented as relative promoter binding, relative to
controls, after subtracting for non-immune rabbit IgG interactions. Data are
represented as the result of four-five samples per condition, run in five
independent experiments. PCR products were run out on 1.5% (w/v) agarose gel
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and results were visualized using a Fluor-S Multiimager (BioRad) and Quantity
One Software (BioRad).

4.3.4 Electromobility shift assays (EMSA)
EMSAs

included

10pmol

GR

consensus

oligonucleotide

(Santa

Cruz

Biotechnology, sc-2545) with 20pmol γ32P-ATP at 6000Ci/mmol (Perkin Elmer,
NEG002Z) along with T4 Polynucleotide Kinase (PNK) Buffer (10X) and T4 PNK
(USB, Cleveland, 70031Y) and water for a total of 50µL. Contents were mixed
well and centrifuged briefly. The reaction was incubated at 37ºC for 30 minutes
followed by termination of the reaction by heating at 65ºC for 10 minutes. The 5’end-labeled oligo was separated from precursor ATP using a QIAquick
Nucleotide Removal Kit (Qiagen, cat# 28304). Radioactivity was quantified using
a liquid scintillation fluid counter. The following 5X binding buffer was prepared
on ice for each sample, 50mM Tris pH 7.5, 20% glycerol, 2.5mM EDTA, 250mM
NaCl, 2.5mM DTT and 10µg poly (di-dC). The 5X binding buffer was then added
to 10µg of nuclear extract, and 1µl labeled probe and water to 20µl and
incubated at room temperature for 20 minutes. Following the incubation either
anti-GR antibody (1µg, Santa Cruz, sc-1002X) or cold competitor probe was
added to the mixture and was incubated for an additional 20 minutes at room
temperature.

Complexes

were

separated

by

5%

polyacrylamide

gel

electrophoresis in 1X TBE buffer, 105V, 45 minutes. Gels were dried via gel
dryer (BioRad Model 583) for approximately 45 minutes and visualized using a
Personal Molecular Imager FX (BioRad) and Quantity One Software (BioRad) at
50µm resolution.
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4.3.5 mRNA isolation
mRNA was isolated using the Oligotex Direct mRNA Mini Kit (Qiagen, Valencia,
CA) per manufacturer’s protocol. The mRNA concentration was determined (OD
260

nm)

using

a

NanoDrop®

ND-1000

spectrophotometer

(NanoDrop

Technologies, Wilmington, DE). Purified mRNA was stored at -80oC.

4.3.6 cDNA synthesis
Reverse transcription reactions were performed in 20 µL following the
manufacturer’s protocol (Invitrogen). A 10µL reaction mixture containing 20ng
mRNA, 500ng oligo dT, 1mM of each dNTP was heated at 65oC for 5 minutes
and quick chilled on ice for 5 minutes. The contents was centrifuged briefly and
1µL RNaseOUT (40units/µL), 2 µL DTT (0.1M) and sterile RNase free water was
added to 19µL. The contents was mixed gently and incubated at 37oC for 2
minutes followed by addition of 1µL (200units) M-MLV reverse transcriptase. The
reaction was then incubated at 37oC for 50 minutes followed by inactivation by
heating at 70oC for 15 minutes. Synthesized cDNA was stored at -20oC until
used. The suitability of the cDNA for PCR was determined using 2 μL of cDNA
added to a 40 µL PCR. A control reaction containing 2µl of purified mRNA was
run without reverse transcription to test for presence of DNA contamination in the
purified mRNA samples. The PCR products were run out on a 1.5% (w/v)
agarose gel and visualized using Fluor-S Multiimager (BioRad) and Quantity One
Software (BioRad).
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4.3.7 Primers
Oligonucleotide sequences for H-Ras and Raf-1 were based on sequences
reported by Revest et al. (2005) and β-actin as reported by Caldwell et al. (2008).
The specificity of each primer pair was confirmed by the identification of a single
PCR product of predicted size on 1.5% (w/v) agarose gels.

4.3.8 Semi-quantitative determination of transcript levels by Real-time PCR
Real-time PCR was conducted in a Gene Amp 7300 sequence detection system
(Applied Biosystems) using a 96-well plate (MicroAmp™ Fast). The relative
quantification of the Ras and Raf genes in different tissue samples was
determined using the 2-ΔΔCt method described by Livak and Schmittgen (2001);
Initially, the ΔCt value, the difference between the average of the triplicate Ct
values for the H-Ras and Raf-1 and the internal control β-actin, for each sample
was calculated (ΔCtsample = ΔCtRas – ΔCtB-actin). Next, the average of the ΔCt
values for the control animals (ΔCtCon
each sample (ΔCtsample – ΔCt

Con Av),

av)

was determined and subtracted from

giving a ΔCt value for each. This was used

to calculate the 2-ΔΔCt value for each. Because 20 is one, the mean 2-ΔΔCt value for
each control sample was approximately one, depending on the variability in the
samples, and the mean 2-ΔΔCt value for the arsenic samples was expressed
relative to one.

4.3.9 Activated ERK Protein
Nuclear fractions from 8 hippocampi from arsenic-exposed and 8 control animals
were analyzed for phosphorylated ERK via western blot according to Buckley et
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al. (2004) and our established protocols. Briefly, extracts were thawed on ice,
diluted in 4X SDS-PAGE sample buffer (Invitrogen, Carlsbad, CA) and heated at
70oC for 10 minutes. Samples (3µg protein per well) were separated using 12%
NuPAGE Bis-Tris gels (Invitrogen) and transferred to 0.45-um-thick nitrocellulose
membranes (Invitrogen). The membranes were blocked with 0.25% I-block
(Applied Biosystems, Foster City, CA) in TBS-T (25mM Tris-HCl pH 7.2, 150mM
NaCl and 0.05% Tween-20) for one hour at room temperature. Blots were then
incubated with a polyclonal primary antibody to anti-phospho-ERK1/2 (1:3,000;
Cell Signaling, 9101) overnight at 4oC.

The reaction was stopped with four

consecutive 5-minute washes in TBS-T. A goat anti-rabbit IgG (H+L):HRP (1:50
000, Thermo Fisher Scientific) was used for the secondary antibody incubation in
0.25% I-block one hour at room temperature. The reaction was stopped with four
consecutive 5-minute washes in TBS-T. Membranes were then incubated in
Supersignal West Pico Working Solution (Thermo Scientific) for five minutes and
exposed to F-BX57 film (Phenix Research Products, Candler, NC). Film was
developed in Kodak D-19 developer then washed and fixed in Kodak fixer. The
blots were then stripped (45 minutes in 10ml Restore Western Blot Stripping
Buffer, Thermo Scientific, 21059) and reprobed for total ERK (1:50,000; Cell
Signaling, 9102) and stripped again and probed for β-actin (loading control)(Cell
Signaling, 4967L). Blotting for ERK 1 and 2 follow the protocol described by
Buckley et al. (2004). The linear range of the phosphorylated and total protein
was calculated to ensure that the protein was not saturating the blot. Control
animals were run on the same blot as arsenic-exposed animals. Gels were run
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and analyzed in duplicate. The developed film was scanned (Hewlett Packard
Scan Jet 5P) and immunoreactivities quantified by measurements of optical
densities using BioRad Quantity-One analysis software. The amount of p-ERK
were compared to the total ERK of the sample and also compared to β-actin and
data were analyzed by t-test.

4.3.10 Statistical analysis
All data were analyzed by t-test comparing the perinatal arsenic to the control.
Significance was set at p ≤ 0.05. Data were analyzed and graphs were generated
using GraphPad Prism (v4.03).

4.4 RESULTS
4.4.1 Arsenic Exposure Paradigm
The dose of arsenic used in present study did not significantly alter maternal
water consumption, maternal body weight, body weights of the newborn pups,
brain wet weights or hippocampal wet weights (Martinez et al., 2008; MartinezFinley et al., 2009).

4.4.2 Chromatin Immunoprecipitation
To determine if GR is able to bind to GREs found in promoters of genes of the
MAPK pathway we used ChIP to assess the in vivo association of GR with Ras
and Raf-1 promoters. Compared to controls, perinatal arsenic animals had lower
GR binding to GREs in the promoters of Ras genes (fig. 4.1A) (t(8) = 2.38;*p =
0.04). Figures 4.1B and 4.1D are representative of the PCR products of each
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real-time run. Compared to controls, perinatal arsenic animals had lower GR
binding to GREs in the Raf-1 promoter (fig. 4.1C) (t(7) = 2.15; p = 0.06), although
not statistically significant there is an obvious reduction in binding. Figures are
the result of four to five samples per condition run in five independent
experiments.

4.4.3 Supershift EMSA
To determine if the decreased binding seen in the ChIP experiments was an
artifact of the reduced GR levels we performed an electrophoretic mobility shift
assay (EMSA). Nuclear hippocampal extracts from perinatal arsenic exposed
and control animals were incubated with a radiolabeled consensus GRE (fig.
4.2). Control and arsenic-exposed samples were incubated with or without antiGR antibody to reveal the presence of GR in the nuclear protein-radiolabeled
GRE complex. The specificity of the EMSA was confirmed by competitition
experiments using unlabeled oligonucleotide sequences in 5-fold molar excess.
The results are representative of four assays. We did not deem it necessary to
stimulate with dexamethasone prior to extracting the nuclear fraction of the cells
as others have shown a modest increase in intensity after stimulation but
presence of the band without stimulation (Tirumurugaan et al., 2008; Barr et al.,
2009). For our purposes, we were solely interested in whether or not binding was
apparent in our treatment group compared to our controls. Results showed that
nuclear extracts from both control and arsenic-exposed animals were able to
bind to a consensus GRE (fig. 4.2). We are unsure whether or not GR is in this
complex as all attempts to probe for GR have turned out unsuccessful. While this
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is important to know, it is not the end of the story as GRs ability to activate
transcription is not always dependent on direct binding of GR to GREs (Reichardt
et al., 1998).

4.4.4 Ras and Raf-1 mRNA levels
To determine if the decreased binding in our ChIP experiment was associated
with a significant reduction in mRNA, we examined Ras and Raf-1 mRNA levels.
In the perinatal arsenic-exposed offspring Ras and Raf-1 mRNA expression was
inhibited as determined by real-time reverse transcriptase-polymerase chain
reaction. Figure 3A Ras mRNA levels (t(16) = 4.35, ***p = 0.0005). Figure 3B
Raf-1 mRNA levels (t(15) = 3.55, **p = 0.003). The Cycle threshold (Ct) values
were determined in triplicate for both groups. The average Ct. values for β-actin,
which was used as a housekeeping gene were not different between the
treatment and control groups. Data are presented as mean ± SEM of eight-ten
litters.

4.4.5 Activated ERK
To assess the effect of lower mRNA levels on activation of the MAPK pathway
we assessed the activation of the downstream target ERK1/2 (fig. 4). ERK1/2
has been implicated in learning and memory, thus it seemed a logical target to
assess. We examined phosphorylated and total ERK1/2 expression levels in both
treatment groups. Treatment with arsenic resulted in decreased phosphorylation
of ERK1/2 (p42/44), as quantified by densitometery and normalized to total levels
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(t(9) = 4.05, **p < 0.003). There was no difference in total ERK1/2 (data not
shown).

4.5 DISCUSSION
We have previously reported decreases in GR and MR levels in hippocampus of
moderate (50ppb) perinatal arsenic-exposed animals leading us to examine the
status of genes that are under the control of the GR. Many components of the
MAPK pathway have been shown to be under this type of control. The MAPK
pathway has been associated with learning and memory and depression, two
behavioral responses that were altered in our animals (Martinez-Finley et al.,
2009; Martinez et al., 2008). In this work we provide evidence for decreased
GR/GRE binding leading to a decrease in transcripts of genes that are under the
control of GR.
Our ChIP-real-time PCR data indicates decreased GR binding at Ras and Raf-1
promoter sites (fig. 4.1A, 4.1C) and lower Ras and Raf-1 mRNA levels (fig. 4.3).
Because many promoters contain GREs, genes other than the ones studied here
could be affected. In support of this possibility, we previously showed increases
in 5-HT1A receptor density in the dorsal hippocampus of our perinatal arsenicexposed mice (Martinez et al., 2008). The 5-HT1A receptor is negatively regulated
by corticosteroids through the GR (Chalmers et al., 1993; Datson et al., 2001; de
Kloet et al., 1986; Meijer et al., 1997). Reduced GR binding to negative GREs
would allow for transcription and ultimately upregulation of the 5-HT1A gene and
may be one example of the consequences of reduced nuclear GRs or reduced
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binding ability. The data from the EMSA experiments show that proteins in the
nuclear fraction of perinatal arsenic-exposed offspring are able to bind to the
synthetic GREs, even though we are unsure as to whether or not GR is in this
complex (fig. 4.2). This is somewhat perplexing but can be explained by the fact
that transcriptional regulation by GR does not require direct association with
GREs, but instead may affect transcription through the presence of other
transcription factors. One caveat of these experiments is that transcriptional
activity of steroid receptors may be dependent not only on specific DNA-binding
elements but also on combinatorial control generated by interactions with other
receptors and additional DNA-binding and non-DNA binding proteins. It is well
recognized that the specificity of the response depends on the tissue and cell
type, as well as on the characteristics of the promoter. At the PND 35 time point
when we are testing, arsenic is no longer detectable in the hippocampal region in
our animals (unpublished results) and therefore cannot be regulating
transcription via a steric hindrance. Our data suggest that there is a deficit in GR
binding to promoter regions in vivo but EMSA results suggest that binding ability
is present when assessed with synthetic GREs. Thus, we suspect that the
inhibition is occurring at the promoter regions. Hypermethylation at these regions
could be a possible mechanism of inhibition that is initiated by arsenic during the
perinatal period. We are currently investigating this theory.
In our studies using gene expression as a tool for toxicity assessment we
detected mRNA effects after moderate (50ppb) perinatal arsenic exposure (fig.
4.3). These lower levels mRNA levels are thought to be mediated by the GR, as
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transcription of Ras and Raf-1 are under the control of GR (Revest et al., 2005).
Rapid actions of GRs on cellular signaling pathways, such as an increase in the
expression levels of components of the MAPK pathway but with a later increase
in the phosphorylated forms of these proteins, have been described (Revest et
al., 2005). Even though we did not measure protein levels of Ras and Raf-1, we
did assess the activation of ERK, which is under control of Ras and Raf-1 (B-raf
is also implicated in brain MAPK signaling but we did not measure these levels
and therefore cannot comment on them here) (reviewed in Avruch, 2007). It is
not always the case that mRNA levels are correlated to protein levels or coincide
with effects on cell function but it has been shown that mRNA levels are more
predictive of protein levels than total RNA levels are (Pradet-Balade et al.,
2001;Greenbaum et al., 2003). Revest and colleagues have shown that the GRmediated activation of the MAPK pathway that culminates in the phosphorylation
of ERK seems to be mediated by an increase in the steady-state levels of
upstream proteins (Revest et al., 2005). If the decrease in activated ERK levels
in our arsenic offspring (fig. 4.4) are indicative of lower protein activity, then it is
possible that this is the result of decreased levels of Ras and Raf-1 proteins.
The MAPK signaling cascade is involved in various forms of synaptic and
behavioural plasticity (Sweatt, 2001) but most importantly for this study, couples
GR activation to ERK phosphorylation. ERK2 phosphorylation was dramatically
decreased in our animals, in the absence of change in total ERK levels (fig. 4.4).
If the amount of Ras and Raf-1 protein is reflected by the degree of
phosphorylation of ERK and the lower levels of Ras and Raf-1 transcripts, the
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data further supports the hypothesis that the MAPK pathway is involved in
mediating the learning and memory deficits in response to GR. The discovery
that ERKs are widely expressed in post-mitotic neurons in the mammalian
nervous system and are activated in response to excitatory glutamatergic
signaling led to the identification of an important role for ERK in synaptic plasticity
and learning and memory (English and Sweatt, 1996; Sweatt, 2001; Thomas and
Huganir, 2004). We have reported deficits in learning and memory tasks in our
perinatal arsenic-exposed mice (Martinez-Finley et al., 2009). Intrahippocampal
infusions of MAPK pathway inhibitors, prior to training, impair memory retention
after training in the Morris Water Maze (Blum et al., 1999; Selcher et al., 1999).
There is new evidence that suggests that the ERK2 isoform is especially
important in learning and memory. A mouse ERK2 knockout study reported
deficits in associative learning in a fear conditioning assay (Samuels et al., 2008).
Satoh and colleagues reported impairment in fear conditioning and deficits in two
spatial memory tasks in ERK2 hypomorphic mice that show a 30% reduction in
ERK2 levels and an overtly normal brain (Satoh et al., 2007).
Arsenic has been shown to disrupt gene transcription in various models
(Hamilton et al., 1998; Kaltreider et al., 2001; Bodwell et al., 2006). Because of
differences in the exposure periods and the in vitro vs. in vivo systems it is
difficult to interpret work presented by others with regard to arsenic and GRmediated transcription. Our perinatal model is a unique view of arsenic disruption
of gene regulation. Prolonged exposure to low concentrations of persistent
neurotoxic environmental pollutants can lead to neuronal dysfunction, particularly
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during development, when the brain is most sensitive. It is difficult to predict the
consequences of long-term dysregulation of GR-mediated transcription, as we
have not followed our mice for longer than 35 days. By analyzing changes in the
gene expression profile of cells exposed to toxicants, it will be possible to find
genes/gene clusters that are commonly or specifically challenged in response to
damage associated with developmental neurotoxicants (Sunol, 2010). Overall,
these data suggest that moderate perinatal arsenic can have long-term effects on
disruption of steroid hormone-regulated gene transcription well into adolescence,
long after the arsenic has been metabolized.
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4.8 FIGURES
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Figure 4.1 Perinatal arsenic exposure reduces glucocorticoid receptor (GR)
binding

to

Ras

and

Raf-1

promoters.

(A)

Results

of

chromatin

immunoprecipitation with anti-GR antibody and nuclear tissue extracts and realtime PCR for Ras (*p = 0.04 vs. control). (B) Gel showing real-time PCR product
bands for Input (positive control), GR and IgG (negative control). (C) Results of
chromatin immunoprecipitation with anti-GR antibody and nuclear tissue extracts
and real-time PCR for Raf-1 (p = 0.06 vs. control). (D) Gel showing real-time
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PCR bands for Input (positive control), GR and IgG (negative control). Results
are presented as relative promoter binding, relative to controls, after subtracting
for non-immune rabbit IgG interactions. Results are representative of five
separate experiments and are presented as mean ± SEM of four-five litters. GR:
Glucocorticoid Receptor; IgG: normal rabbit IgG
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Figure 4.2 Perinatal arsenic exposure does not affect GRE binding in
nuclear extracts. Bands labeled as ‘bound’ are the result of binding of [32P]labeled consensus GRE with nuclear proteins from arsenic-exposed and control
hippocampal tissue resulting in a ‘shift’ of the complex on the gel versus the free
probe. Free probe represents [32P]-labeled consensus GRE that was run in the
absence of nuclear extract. Specificity was determined using [32P]-labeled
consensus GRE along with 5-fold molar excess cold oligonucleotide and labeled
as Cold Competitor (CC). In this figure the CC was incubated along with the first
control sample. Result is representative of eight independent experiments.
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Figure 4.3 Reduced MAPK pathway mRNA levels in perinatal arsenicexposed offspring compared to controls. (A) Ras mRNA levels in arsenicexposed offspring and controls (***p = 0.0005 vs. control). (B) Raf-1 mRNA levels
in arsenic-exposed offspring and controls (**p = 0.003 vs. control). Results are
expressed as a percentage of the Ras or Raf signal to the β-actin signal, relative
to control animals, and are presented as mean ± SEM of eight-ten litters.
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Figure 4.4 Activated ERK in hippocampal nuclear subcellular fraction. (A)
Representative western blot of p-ERK1/2, total ERK1/2 and β-actin in the nuclear
compartment of perinatal exposed mice. (B) Quantitation of p-ERK, total ERK,
and B-actin bands in hippocampal nuclear subcellular fraction of arsenic exposed
mice was based on densitometric analysis (**p = 0.003 vs. control). Results are
expressed as a percentage of the p-ERK2 signal to total ERK2 signal, relative to
control animals, and are presented as mean ± SEM of five-six litters.
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Chapter 5. CONCLUSIONS
5.1 OVERALL FINDINGS
At the onset of this dissertation project it was known that arsenic is capable of
inducing toxicological effects in multiple body systems, while less was known
about its neurotoxicity. Further, prior to our studies there was limited information
on arsenic as a prenatal insult and an incomplete description of the mechanistic
damage. The overall goal of our research was threefold. The first goal was to
reveal whether or not arsenic exposure, at levels commonly seen in drinking
water in the US, was detrimental to learning. The second was to give some
indication of exposure time periods (gestational vs. postweaning) when cognitive
function would be particularly susceptible to damage by arsenic. And the third
was to explore a mechanism for arsenic damage which could explain the
cognitive deficits reported in human populations.
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Figure 5.1 Diagram of arsenic-induced changes in perinatal-exposed offspring
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Learning and memory impairments after exposure to arsenic were first described
in a Mexican study in 2001 (Calderon et al., 2001). That report was soon followed
by others (from different countries) that correlated learning and memory deficits
in adolescents to arsenic exposure (Wasserman et al., 2004; von Ehrenstein et
al., 2007). The arsenic-exposure model developed in the present studies
displayed measurable deficits in learning and memory (figs. 3.3-3.4) and
depressive-like behavior (figs. 2.6-2.7) similar to those reported in human
studies. Results from the novel object exploration test revealed deficits in latency
to the novel object and in number of center entries in perinatal-exposed animals
indicating that arsenic-exposed animals have learning and memory deficits (fig.
3.3). The 8-way Radial Arm Maze illustrated that arsenic-exposed offspring have
difficulties performing more arduous hippocampal-sensitive learning tasks (fig.
3.4). Arsenic-exposed offspring failed to make improvements in the task as the
days progressed. While unable to definitively link these behavioral alterations to
a specific neurochemical change, our data strongly implicate deficits in
glucocorticoid regulation of gene expression. In support of this conclusion was
the finding that arsenic induced lower GR levels (figs. 3.1 and 5.1) and produced
deficits in GR-mediated transcription of genes within the MAPK pathway (figs.
4.1, 4.3 and 5.1) critical for learning and memory. These findings add to the
overall picture of arsenic neurotoxicity by describing the learning deficit in a
rodent model after moderate (50ppb) exposure, identifying the perinatal period as
a susceptible time period for arsenic-induced damage and by providing a
possible mechanism of arsenic damage in the brain.
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5.2 LIMITATIONS
In our mouse model, moderate perinatal arsenic exposure produced deficits in
learning and memory. However there are several limitations to our current set of
studies. First, it is difficult to directly link a behavioral deficit, like learning and
memory, to an environmental insult or to a particular neurochemical mechanism
of that insult. For example, arsenic is likely to cause a number of cellular
changes,

including

disruption

of

zinc-associated

proteins

(reviewed

in

Beyersmann and Hartwig, 2008), inhibit DNA repair (Qin et al., 2008; reviewed in
Gentry et al., 2010), induce chromosomal aberrations (reviewed in Salnikow and
Zhitkovich, 2008), alter apoptosis (Pi et al., 2005), induce oxidative stress
through hydroxyl radical formation (Shi et al., 2004) as well as other
mechanisms. To accomplish a direct causal connection between perinatal
arsenic and the subsequent adolescent behavior, we would need to be able to
reverse the effect at a molecular level and restore normal learning in the animal.
At this point, the best that we can do is correlate the presence of the behavior to
the disruptions in the MAPK pathway, as several studies support a requirement
for the MAPK/ERK pathway genes in hippocampal-sensitive associative and
spatial learning (Sweatt, 2004).
While MAPK gene expression is necessary for learning, there are other
biochemical pathways which, if damaged, will also lead to failed learning
performance. The impaired performance found in our studies could be explained
by loss of nuclear MR, which was seen in the arsenic-exposed mice. Findings
from mutant mice with inactivated MR showed impaired learning of the water-
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maze task and deficits in measures of working memory on the radial arm maze,
as well as hyperreactivity toward a novel object, but normal anxiety-like behavior
(Berger et al., 2006). Alternatively, anxiety differences between the treatment
groups could have been misinterpreted as performance deficits. Habituation to
the novel object open field prior to testing should have ameliorated this concern.
The 8-way Radial Arm Maze illustrated that arsenic-exposed offspring have
difficulties performing more arduous hippocampal-sensitive learning tasks (fig.
3.4). Arsenic-exposed offspring failed to make improvements in the task as the
days progressed. If the arsenic mice had a reduced anxiety response, the mice
would have displayed a greater willingness to enter the maze arms and this was
not seen in our study.
A reported effect following oral exposure to inorganic arsenic is the development
of peripheral neuropathy (ATSDR Arsenic, 2007). It is not possible that the
learning and memory behaviors that we have seen are due to decreased
ambulation as a result of peripheral neuropathy. We ran measured quadrant
crossing in both the novel object and radial arm maze as well as measured
startle response in these animals and found that the perinatal arsenic animals
ambulated just as much as controls (data not shown).
Another limitation to the studies described in this dissertation is that the effects of
arsenic were assessed in adolescents long after the perinatal exposure. The
temporal separation between the exposure and the measurements makes it
more difficult to correlate the two events because of the possibility that
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experiences occurring in the intervening period could have contributed to the
altered phenotype. There is an added level of difficulty in determining if the
effects are a direct result of the toxin itself or a secondary, indirect effect of the
exposure on the mother. The delivery of arsenic was to the pregnant dam and
not to the developing fetus, thus, the maternal response to the toxin can produce
its own insult. An example of this is the high plasma corticosterone levels that we
have reported in our perinatally exposed animals, which was assessed under
baseline, non-stressed circumstances (fig. 2.1). It is unclear whether those levels
are the direct result of arsenic or the result of the mother’s response to the
arsenic during gestation. The absence of the elevated basal CORT in the
postnatal exposure group (fig. D1) suggests that the high levels seen in our
perinatal animals may be a result of the mother’s response to the arsenic. While
this may be the case, it doesn’t make it any less of a problem in our perinatal
animals. More research needs to be done to parse out what the effect of high
CORT is versus the effect of the arsenic exposure. Even if high CORT is the
result of the maternal response to arsenic exposure producing a programming
change in the fetal HPA axis and not a direct fetal response to the presence of
arsenic, our conclusions in these studies would remain unchanged.
Initial analysis of the high corticosterone suggested that the HPA axis was
overactive in the perinatal arsenic-exposed offspring. A dexamethasonestimulated corticosterone response was measured to determine the functionality
of the negative feedback pathway at the level of the adrenals of the HPA axis.
Although we had a small sample size, our results indicate that the HPA axis has
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a higher set point in perinatal arsenic-exposed animals but can elevate
corticosterone levels in response to a stressor (saline injection) and inhibit
corticosterone secretion in response to dexamethasone in accordance with
negative feedback regulation (fig. A.1). These results indicate that, at the level of
the adrenals, the HPA axis responds ‘normally’ (fig. A.1). However, we did not
measure CRF or ACTH secretion and thus cannot remark on the status of the
receptors at these levels nor can we conclusively say that the regulation at either
the hypothalamus or the pituitary is ‘normal.’ We can conclude from this test that
the amount of regulation present is enough to dampen the amount of
corticosterone secreted after DEX administration, an outcome that is present in a
‘normal,’ intact HPA axis. To better characterize regulation of the axis, a CRFstimulated ACTH/CORT response should be a focus of future studies. This type
of test would give us more information about the functioning of the negative
feedback arm of the HPA axis at the level of the pituitary.
Results from the present experiments revealed lower abundance of hippocampal
cytosolic GRs in perinatal arsenic-exposed offspring compared to controls but no
difference in the abundance of cytosolic MRs. Nuclear levels of both GR and MR
were significantly lower than those of controls (Martinez-Finley et al., 2009). A
plausible explanation for lower nuclear GR and MR levels is failure of the
receptors to traffic to the nucleus. While other groups have investigated this
possibility and found that the trafficking of these receptors to the nucleus is
unaffected by arsenic (Kaltreider et al., 2001), these studies were conducted
using a hepatoma cell line and the results may not be the same in the brain.
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Differential programming of the GR in different tissues has been shown and is
attributed

to

the

presence

of

multiple

tissue-specific

alternate

first

exons/promoters of the GR gene (Seckl and Meaney, 2004). In addition, the cell
line fails to maintain the contribution of the intact HPA axis and does not account
for genes that may have previously been affected. For example, high CORT
levels have been shown to reduce dynein cytosplasmic intermediate chain 1
gene expression, reducing motor protein activity and axonal transport (Morsink et
al., 2006), a result that would not have been taken into account in the hepatoma
cell line. In accordance with our high CORT, the translocation of GR to the
nucleus by dynein may be reduced. Lower levels of nuclear GR and MR would
have far-reaching consequences on gene transcription. It has been shown that,
in particular for GR, nuclear translocation of the activated receptor and its ability
to induce transcriptional activity are intimately correlated (de Kloet et al., 2009).
We tested GR transcriptional activity of two genes of the MAPK pathway and
found reduced binding of GR to their promoters (fig. 4.1) and reduced mRNA
levels in our perinatal arsenic-exposed animals compared to controls (fig. 4.3).
Arsenic’s inhibition of GR binding at Ras and Raf-1 promoters (fig. 4.1) is not
likely to be due to steric hinderance affecting the binding of GR to the GRE
because arsenic levels were undetectable in hippocampal tissue at the 35 day
time point, when our tests were conducted (data not shown). Although we are not
certain what the exact mechanism might be, based on our ChIP data, we suspect
that there is a decrease in GR-GRE binding ability (fig. 4.1). A coimmunoprecipitation study targeting the transcription cofactors that interact with
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GRE-bound GR may show a decreased association with GR in pre-exposed
animals. An alternative explanation for the reduced levels of Ras and Raf
expression is that arsenic does not inhibit GR binding to GRE; rather it inhibits
recruitment of the transcription machinery. However, our EMSA data, which
shows binding of nuclear protein with synthetic GREs, suggest that nuclear
proteins are able to be recruited and bind to a GRE, although we are unsure
whether or not GR is in the complex. Given these observations, it is possible that
arsenic could induce changes in methylation at promoter sites which would
reduce expression of Ras and Raf and would explain the lack of an arsenic effect
in the EMSA data (fig. 4.2). Methylation appears to influence gene expression by
affecting the interactions with DNA of both chromatin proteins and specific
transcription factors (Razin and Cedar, 1991). Our EMSA data (fig. 4.2) show
that nuclear proteins from both arsenic-exposed and control animals are able to
interact with synthetic GREs, suggesting that the binding problem in our ChIP
data (fig. 4.1) may be the result of changes in the in vivo promoters. There can
be multiple methylation sites in promoters, which will change how tightly the
chromatin is bound and what types of interactions can occur. If there were
hypermethylation in our arsenic-exposed animals, then we would expect to see
reduced binding of GR in in vivo promoters but not in synthetic sequences, which
is what our ChIP and EMSA data report.
The perinatal period, defined in our model from gestational day 1 through PND
23, encompasses the key developmental periods in most species; the brain is
particularly vulnerable during development and the damage induced by
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neurotoxic agents is likely to be long-lasting. This period is critical because it
influences how the animals will respond to their external environment throughout
their lives. Prenatal glucocorticoid excess or stress might link fetal maturation
and adult pathophysiology, as prenatal glucocorticoid exposure permanently
increases basal plasma corticosterone levels and reduces GRs and MRs in the
hippocampus in adult rats (Seckl and Meaney, 2004). Our perinatal exposure
period could be affecting the establishment of regulation of the HPA axis,
enabling sustained or cumulative damage with further high CORT levels resulting
in an inability to return to homeostasis and prevent a maladaptive overshoot. It is
well established that chronically elevated levels of CORT, mediated by the
binding to GRs and MRs, produce cognitive deficits (de Kloet et al., 2005, Joels
et al., 2007; McEwen, 2007). A drawback of these studies is that we have not
followed the perinatal-exposed animals past the 35 day time point to determine if
deficits are persistent or can be recovered after a significant amount of time. In
addition, we have reported that the hippocampal formation is one of the brain
regions most susceptible to the consequences of perinatal arsenic exposure. Our
studies have focused on the hippocampus, although other areas of the brain may
also be affected. Also, learning and memory, although tied to the hippocampus,
is also dependent on other areas of the brain, which we have yet to examine. It is
reasonable to consider these other areas as arsenic is not preferentially
sequestered in the hippocampus (Sanchez-Pena et al., 2010).
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5.3 FUTURE DIRECTIONS
Further studies detailing the molecular effects of perinatal arsenic exposure on
the central nervous system are essential to our understanding of arsenic’s
production of learning and memory deficits. Potential leads to follow include
epigenetic effects, mainly changes in DNA methylation, as this has been shown
to be important in long-term fetal programming and could be the mediator of the
changes that we have shown. A second study would involve the assessment of
other brain regions to determine the amount of damage associated with those
areas and their contribution to the observed behavioral deficits. Future directions
could also include monitoring the animals after a significant amount of time
unexposed to see if the damage is persistent into later adulthood.

5.4 CONCLUSIONS
While a direct link between the poor performance in these behavioral tasks and
reduced GR levels is not established by these studies, the findings are consistent
with the interpretation that memory performance is affected by arsenic-induced
decreases in GR and decreases in GR-mediated transcription of the MAPK
pathway in the hippocampus. Overall the data suggest that moderate perinatal
arsenic exposure can have effects on learning and memory and HPA axis
function well into adolescence, consistent with the Fetal Basis of Adult Disease
hypothesis (White et al., 2007), which postulates that many adult diseases have
a fetal origin.
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APPENDIX A: PERINATAL ARSENIC-EXPOSED ANIMALS HAVE NORMAL
HPA NEGATIVE FEEDBACK REGULATION
Rationale: Due to the elevated CORT levels and lower levels of GRs in our
perinatal exposed animals we chose to evaluate whether or not the arsenicexposed offspring could produce a ‘normal’ stress response. A DEX-stimulated
CORT response was measured to determine the functionality of the negative
feedback arm of the HPA axis. Dexamethasone, a synthetic corticosteroid acting
through GRs, when administered two hours prior to CORT measurement should
have the effect of suppressing the secretion of CORT in accordance with
negative feedback regulation. We did not measure CRF or ACTH secretion and
thus cannot remark on the status of the receptors at these levels nor can we
conclusively say that the regulation at either of these levels is ‘normal.’ We can
conclude from this test that the amount of regulation present is enough to
dampen the CORT response after DEX administration, an outcome that is
present in a ‘normal,’ intact HPA axis.
Experimental Design and Data Analysis: Mice were given an intraperitoneal
injection

of

dexamethasone

(0.1mg/kg)

or saline (0.1mg/kg) at 0900.

Dexamethasone (Sigma-Aldrich cat #46165) was reconstituted in saline (0.91%
w/v). The mice were then sacrificed by rapid decapitation 2 hours post injection
and trunk blood was collected in EDTA-coated tubes. Plasma was separated and
corticosterone levels were evaluated using a

125

I-RIA Corticosterone Kit for

Rats/Mice (MP Biomedicals). Cort levels were analyzed by t-test comparing the
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perinatal arsenic animals to the controls. Statistical significance was set at p ≤
0.05.
Results:
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Figure A.1 The effect of DEX or saline administration on corticosterone negative feedback.
Data bars represent the mean + SEM nanograms corticosterone per mL plasma from one or
three mice per treatment group.

Conclusions: The perinatal arsenic-exposed offspring appear to have higher
basal CORT levels, confirming what we have previously published (Martinez et
al., 2008). The higher baseline corticosterone seen in the perinatal-arsenic
exposed animals does not appear to have an effect on their negative feedback
response as they are able to lower the amount of CORT secreted in response to
Dexamethasone administration. The arsenic-exposed animals are also able to
mount a response as seen in the saline test, thus they have not reached a
maximum level of CORT secretion. This data suggests that the perinatal exposed
mice do not have a dysregulated HPA axis because the results suggest that the
negative feedback regulation is intact.
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APPENDIX B: INTRODUCTION TO POSTNATAL EXPOSURE
B.1 Rationale Behind Postnatal Exposure Model
Many of the changes that we have reported (Martinez et al., 2008; MartinezFinley et al., 2009) in the perinatal arsenic-exposed mice could be the result of
the sensitivity of the time of exposure as the developmental time period is a
particularly sensitive time. One question that has not been addressed is whether
or not the time of exposure to arsenic matters; both perinatal and postnatal
arsenic exposure could potentially produce the deficits that we have reported.
Thus far, epidemiological studies have been unable to separate the perinatal and
postnatal exposure periods. Consequently, it is uncertain as to whether or not
exposure to arsenic during development is more damaging than postnatal
exposure. Postnatal acute arsenic exposure studies were run alongside the
perinatal arsenic exposure studies and compared to control groups. The goal of
this postnatal model was to discern if the deficits seen in arsenic exposed
populations are due to developmental changes or due to a direct effect of the
metal on nervous system functioning. This discernment becomes especially
important when considering the moderate levels of arsenic which we are testing.
The postnatal acute exposure paradigm was a short-term 50ppb exposure period
occurring after weaning and lasting until day 35, when the animals were tested.
We began the studies by looking for the learning and memory deficits. The
results of those tests increased the importance of testing the acute postnatal
group in other parameters to distinguish the developmentally linked with the
acute arsenic effects. Postnatal arsenic exposure was well tolerated, as seen in
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drinking water consumption, and did not result in overt toxicity, as seen in body,
whole brain and hippocampal weights and litter sizes. Total inorganic arsenic
concentrations detected in brain tissue of offspring at 35days of age were
measured. Control brain levels were 1.0 ± 0.24 ppb and postnatal arsenic
offspring levels were 3.18 ± 1.27 ppb. Levels of arsenic in the postnatal exposure
group exceeded controls but was not significant due to the small sample size
(t(5) = 1.98, p ≥ 0.05).

Amount consumed (g/day)

Offspring Drinking
15

10

5

0
Control

Postnatal Arsenic

Figure B.1 Presence of arsenic in drinking water had no effect on amount consumed.
The presence of arsenic in the drinking water had no effect on the amount consumed (p ≥ 0.05,
not significant).
Treatment

Litter Size

Whole body

Whole brain

Hippocampal

weight at PND35

weight at

weight at

PND35

PND35

Control

5.333 ± 0.802

16.94 ± 0.158

0.485 ± 0.011

0.036 ± 0.003

Postnatal As

7.714 ± 0.918

18.25 ± 0.133*

0.481 ± 0.008

0.040 ± 0.005

Figure B.2 Effect of postnatal arsenic exposure on litter size, whole body, whole brain and
hippocampal weights.
There was no effect of arsenic on litter size, whole brain or hippocampal weights D35 (p ≥ 0.05,
not significant). There was an effect on whole body weight at D35, with arsenic-exposed animals
weighing slightly more than controls (*p≤ 0.05). PND = Postnatal Day
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APPENDIX C: IMPACT OF MODERATE POSTNATAL ARSENIC EXPOSURE
ON SPATIAL AND NON-SPATIAL LEARNING AND MEMORY BEHAVIOR
Rationale: Epidemiological analysis has shown learning deficits in adolescents
exposed to high concentrations of arsenic in drinking water (Calderone et al.,
2001; Wasserman et al., 2004; von Ehrenstein et al., 2007). We examined the
impact of postnatal arsenic exposure on two types of hippocampal learning tasks,
nonspatial and spatial. The radial arm maze is a hippocampal-dependent task
used to measure spatial learning and memory. The novel object recognition task
is a nonspatial task which tests hippocampal and frontal cortical function (Baker
and Kim, 2002). The 8-way radial arm maze was selected because it should be a
sensitive measure of hippocampal spatial memory and the number of trials can
be altered to either increase group differences or increase group reliability.
Experimental Design and Data Analysis: Radial Arm Maze: Radial arm maze
testing was conducted using the mouse runway system from Coulbourn
Instruments (Whitehall, PA) using a protocol modified from Egashira et al. (2002).
Plastic food cups containing sweetened condensed milk as a reinforcer, were
placed approximately 2/3rds the way down in each arm. The maze was located
in a room containing many extra-maze visual cues. Arm entry was recorded by
an observer seated several feet away from the maze. All mice were habituated to
the maze for 20 minutes on the day prior to testing. One week before testing,
mice were placed on a caloric restriction diet where they received 3 grams of lab
chow (7004 Harlan Teklad S-2335, Denver, CO) each day. Untreated tap water
was available ad libitum. Testing was conducted over 3 consecutive days. For
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each 8 minute testing session, the mouse was placed in the center of the maze.
For each testing session; the number of correct choices in the initial eight chosen
arms and the number of errors which was defined as choosing arms which had
already been visited were scored. Novel Object Exploration: The novel object
exploration task was conducted in a plexiglas open field apparatus (43 cm x 43
cm x 21 cm high, designed by Allan laboratory) using a protocol described
previously by Grailhe et al. (1999). The floor of the apparatus was black and
divided into five areas: Four equal quadrants and one center area 14 cm. in
diameter. The experiments were conducted in a dimly lit room with the aid of a
video camera to minimize subject stress and anxiety. The floor and walls of the
open field were wiped with 70% isopropanol before each test session. Each test
consisted of two videotaped five-minute sessions. During the first session, mice
were placed in the center area and allowed to explore and acclimate to the
apparatus. A novel object, consisting of a pink and green striped gray cube (2.5
cm3) with an open side (designed by Allan laboratory), was placed in the center
area with the open side facing the mouse. Response to the novel object during
the second five minute session was videotaped. Subsequently, a trained
observer blinded to experimental group identity analyzed the video tapes and
measured latency to approach the object and total number of center line crosses
in the presence of the novel object. Data were analyzed via t-test using
GraphPad Prism (V.5)
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Figure C.1 Effects of postnatal arsenic-exposure on number of entry errors in 8-way Radial
Arm Maze at D35.
Day 1 represents first day after acclimation period. Data are presented as mean ± SEM of five
litters.
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Figure C.2 Effects of postnatal arsenic exposure to 50ppb arsenic on novel object
exploration at D35.
(A) Latency to approach novel object after acclimation period (*p < 0.03 vs. control). (B) Entries to
center in the presence of the novel object (**p < 0.007 vs. control). Data are presented as mean ±
SEM of four-seven litters.
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Conclusions: Novel object test revealed a significant increase in latency to novel
object in arsenic-exposed offspring compared to controls. Arsenic mice did not
improve in number of entry errors in the 8-way radial arm maze as days
progressed, similar to the perinatal exposed mice but unlike the controls. These
data suggest that postnatal-arsenic exposed mice take longer to process novel
information and fail to learn when challenged with hippocampal-dependent,
spatial learning and non-spatial memory tasks.
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APPENDIX D: IDENTIFYING POSTNATAL ARSENIC-INDUCED CHANGES
WITHIN THE HYPOTHALAMIC-PITUITARY-ADRNEAL (HPA) STRESS AXIS
Rationale: The HPA axis findings in our perinatal arsenic exposed animals led
us to question the integrity of components of the HPA axis in our postnatal
arsenic-exposure model. As a result we evaluated corticosterone levels and
nuclear and cytosolic GR levels in our postnatal arsenic animals. A DEXstimulated CORT response was measured in addition to the basal CORT levels.
Analysis of the levels of HPA hormones and receptors gave insight into the
status of the feedback regulation in the postnatal exposure model.
Experimental Design and Data Analysis: CORT Levels: Litter mates of the
mice tested in the behavioral tests were used in these studies. Five to six mice
per treatment group were used. Radioimmunoassay (RIA) kits were used,
according to manufacture instructions for CORT using manufacturer established
protocols. Taking into account circadian rhythms, blood was taken between the
hours of 0800 and 1000 to minimize variance. Plasma concentrations of CORT
were determined through standard curve analysis. When we failed to get enough
plasma from one animal, blood from males from the same litter were pooled and
used for the analysis Comparisons between the arsenic treatment group and the
corresponding control group was via t-test. Dexamethasone Suppression Test:
Mice were given an intraperitoneal injection of dexamethasone (0.1mg/kg) or
saline (0.1mg/kg) at 0900. Dexamethasone (Sigma-Aldrich cat #46165) was
reconstituted in saline (0.91% w/v). The mice were then sacrificed by rapid
decapitation 2 hours post injection and trunk blood was collected in EDTA-coated
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tubes. Plasma was separated and corticosterone levels were evaluated using a
125

I-RIA Corticosterone Kit for Rats/Mice (MP Biomedicals). GR Receptor:

Adolescent offspring, 35-40 days of age, were sacrificed by decapitation and
whole hippocampal formation rapidly dissected. Subcellular fractions are
prepared exactly as described by Buckley et al. (2004). Protein determinations
were performed as described in Weeber et al. (2001) and were used to load
equal amounts of protein in each well. To determine the lack of cytoplasmic
contamination in the nuclear fraction, the membrane was probed between 68kDa
and 21 kDa for anti-A-Raf (1:500; Santa Cruz) and anti-H-Ras (1:500; Santa
Cruz) antibodies, respectively. Cytosolic and nuclear fractions from seven or
eight hippocampi from arsenic-exposed and control animals were analyzed for
GR via western blot. The linear range of the total protein was calculated to
ensure that the protein was not saturating the blot (data not shown). Control
samples were run on the same blot as arsenic-exposed samples. The amount of
total GR of the sample was corrected for Beta-actin and data analyzed by t-test.
Extracts were thawed on ice, diluted in 4X SDS-PAGE sample buffer (Invitrogen,
Carlsbad, CA) and heated at 70°C for 10 minutes. Samples (2ug protein per well
GR) were separated using 4-12% NuPAGE Bis-Tris gels (Invitrogen) and
transferred to 0.45-um-thick nitrocellulose membranes (Invitrogen). The GR
membranes were blocked with 0.25% I-block (Applied Biosystems, Foster City,
CA) in TBS-T (25mM Tris-HCl pH 7.2, 150mM NaCl and 0.05% Tween-20) for
one hour at room temperature. Blots were then cut and incubated with either a
polyclonal primary antibody to GR (1:3,000; M-20, Santa Cruz Biotechnology,

126

Santa Cruz, CA) or B-actin (1:2,000; Cell Signaling, Boston, MA) overnight at
4°C. The reaction was stopped with four consecutive 5-minute washes in TBS-T.
A goat anti-rabbit IgG (H+L):HRP (1:50,000, Thermo Fisher Scientific, Rockford,
IL) was used for the secondary antibody incubation in 0.25% I-block one hour at
room temperature. The reaction was stopped with four consecutive 5-minute
washes in TBS-T. Membranes were then incubated in Supersignal West Pico
Working Solution (Thermo Scientific) for five minutes and exposed to F-BX57 film
(Phenix Research Products, Candler, NC). Film was developed in Kodak D-19
developer then washed and fixed in Kodak fixer. The developed film was
scanned (Hewlett Packard Scan Jet 5P) and immunoreactivities quantified by
measurements of optical densities using BioRad Quantity-One analysis software.
Each protein sample was run in duplicate and the average optical density taken.
All data were analyzed by t-test comparing the perinatal arsenic to the control on
each of the dependent measures. Statistical significance was set at p ≤ 0.05.
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Figure D.1 The effect of moderate postnatal arsenic exposure on plasma corticosterone
levels.
Data bars represent the mean + SEM nanograms corticosterone per mL plasma from five or six
mice per treatment group. There was not a significant difference in plasma corticosterone levels
compared to the control water group (p ≥ 0.05; not significant).
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Figure D.2 The effect of saline or DEX administration on corticosterone negative feedback.
Data bars represent the mean + SEM nanograms corticosterone per mL plasma from one or
three mice per treatment group. There was not a significant difference in plasma corticosterone
levels compared to the control group (p ≥ 0.05; not significant).
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Figure D.3 Nucleocytoplasmic trafficking of GRs and densitometric quantitation of GR
bands.
(A) Quantitation of GR bands in cytosolic subcellular fraction of arsenic exposed mice was based
on densitometric analysis (p > 0.05 vs. control). (B) Quantitation of GR bands in nuclear
subcellular fraction of arsenic exposed mice was based on densitometric analysis (*p < 0.05 vs.
control). The anti-GR polyclnal antibody recognized a prominent band at ~95kD, representative of
GRα. Results are expressed as a percentage of the GR signal to B-actin signal, relative to
controls and are presented as mean ± SEM of seven-eight litters.
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Conclusions: The postnatal exposure model revealed basal corticosterone
levels similar to those seen in the controls. Dex-stimulated cort response was
also similar to that of controls, indicating that both the setpoint and reponse to
stimulation of the axis was not altered by presence of arsenic. Nuclear levels of
GR were not different than controls; however there was a slight decrease in
amount of cytosolic receptor relative to controls but not as robust a decrease as
in the perinatal animals. Given these findings it is likely that the deficits reported
in our perinatal arsenic animals are due to the sensitive perinatal time period.
Although we cannot completely rule out the significance of having arsenic onboard because it may be that the exposure period in our postnatal animals is not
long enough to elicit deficits in HPA axis parameters.
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APPENDIX E: POSTNATAL ERK DATA
Rationale: Extracellular-signal regulated kinase (ERK) has been shown to be
required in many different forms of learning in many species. Activation of the
MAPK pathway leads to ERK phosphorylation (and ultimately its activation). In
most cases, the effects on p-MAPK levels are not accompanied by changes in
total MAPK levels. It is postulated that GR-activated transcription can ultimately
lead to ERK phosphorylation (Revest et al., 2005). Therefore, arsenic inhibition of
GR-induced transcription will ultimately lower the level of ERK phosphorylation.
P-ERK has been shown to be important in molecular mechanisms for learning
and memory.
Experimental Design and Data Analysis: Nuclear fractions from 5-8
hippocampi from arsenic-exposed and control animals were analyzed for
phosphorylated ERK via western blot according to Buckley et al. (2004) and our
established protocols (Martinez et al., 2008; Martinez-Finley et al., 2009). The
blots were stripped and reprobed for total ERK and stripped again and probed for
B-actin (loading control). Control animals were run on the same blot as arsenicexposed animals. Gels were run and analyzed in duplicate. The amount of pERK was compared to the total ERK of the sample and also compared to B-actin
and data were analyzed by t-test.
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Results:

Normalized Ratio
(p-ERK2/Total ERK2)

1.75
1.50
1.25
1.00

***

0.75
0.50
0.25
0.00
Control

Acute

Figure E.1 Activated ERK in hippocampal nuclear subcellular fraction.
Quantitation of p-ERK, total ERK, and B-actin bands in hippocampal nuclear subcellular fraction
of postnatal exposed mice was based on densitometric analysis (***p < 0.0001 vs. control).
Results are expressed as a percentage of the p-ERK2 signal to total ERK2 signal, relative to
controls, and are presented as mean ± SEM of nine-ten litters.

Conclusions: There was a decrease in activated ERK2 levels compared to
controls. Lower levels of p-ERK could provide a mechanistic rationalization for
the deficits in learning and memory observed in the arsenic-exposed mice.
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APPENDIX F: OVERALL CONCLUSIONS FROM POSTNATAL DATA
To determine if the changes that we reported (Martinez et al., 2008; MartinezFinley et al., 2009) in the perinatal arsenic-exposed mice were the result of the
sensitivity of the time of exposure, we ran a subset of tests using an acute
postweaning model. Results from the postnatal exposure model helped tease out
which effects reported in the perinatal group were the direct result of arsenic onboard and which were the result of insults during the sensitive perinatal period.
Novel object test revealed a significant increase in latency to approach the novel
object in arsenic-exposed animals compared to controls (fig. C.2) along with a
decrease in number of center entries in the presence of the novel object (fig. C2).
These findings are consistent with the perinatal data. Postnatal arsenic-exposed
mice did not improve in number of entry errors in the 8-way radial arm maze as
days progressed (fig. C.1), similar to the perinatal exposed mice and unlike the
controls (fig. 3.4). Collectively, these data suggest that postnatal-arsenic exposed
mice take longer than controls to process novel information and fail to make the
proper adjustments when challenged with hippocampal-dependent, spatial
learning and non-spatial working memory tasks. The fact that we were able to
elicit a learning and memory deficit in the postnatal exposure model (figs. C1-C2)
indicates that the perinatal exposure period is not the only time-period that is
sensitive to arsenic.
In the molecular studies, postnatal arsenic exposure decreased activated ERK2
levels compared to controls (fig. E.1) similar to those seen in the perinatal studies
(fig. 4.4). Lower levels of p-ERK could provide a mechanistic rationalization for
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the deficits in learning and memory observed in the arsenic-exposed mice. The
learning and memory tests along with the ERK data suggest that arsenic is
working through a similar mechanism in both exposure paradigms. We do not
have enough data on the postnatal model to implicate the MAPK pathway in the
learning and memory deficit but the ERK data suggests that the MAPK pathway
may be involved, as ERK is one of the major MAP kinases.
The postnatal exposure model produced basal corticosterone levels similar to
those seen in the controls (fig. D.1). However, when arsenic exposure occurs
during the early developmental period as in the perinatal exposure model, basal
corticosterone levels are significantly higher than controls (fig. 2.1), suggesting
that the HPA axis is sensitive to arsenic damage during critical periods of the axis
development. In support of this conclusion, the dexamethasone (DEX)-stimulated
corticosterone response in the postnatal arsenic-exposure group was also similar
to that of controls (fig. D.2), indicating that both the set point and response to
stimulation of the axis were not altered by presence of arsenic when given at this
later

time

point

during

development.

Given

that

the

DEX-stimulated

corticosterone response was also intact in the perinatal group it appears likely
that the perinatal animals have a higher set point but are able to both suppress
and mount a stress response (fig. A.1).
There were some specific changes in the postnatal arsenic-exposure mice in the
subcellular levels of glucocorticoid receptor. While postnatal nuclear levels of GR
were not different than controls; there was a slight decrease in amount of
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cytosolic receptor relative to controls. This decrease in the cytosolic GR fraction
was not as robust a decrease as in the perinatal animals (figs. D.3, 3.1 and 3.2)
suggesting that the degree of arsenics impact on GR distribution levels is
dependent upon the timing of arsenic exposure.
The pattern of HPA axis damage as a result of either prenatal or postnatal
arsenic exposure is variable with some measures not affected (fig. D1-D3) while
others are affected to a differing degree (fig. D2). These data indicate that
arsenic-induced damage to the HPA axis may be dependent upon the
developmental stage of the axis. The overall mechanism of arsenic damage may
be different in the two exposure paradigms. A careful assessment of pre- and
postnatal exposures could be helpful in identifying the sensitive time points and
the aspects of the HPA axis that are affected during the critical periods.
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